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8ABSTRACT
Background: The bacteriology, the clinical picture and the treatment of otitis media (OM) have
changed over the last decades. New bacterial species, like Alloiococcus otitidis, are suggested to
be associated with OM and severe complications of OM are encountered only rarely.
Methods: 118 children with acute otitis media (AOM) and 123 children with otitis media with
effusion (OME) were included in two separate bacteriological studies using bacterial culture and
polymerase chain reaction (PCR). In the two retrospective studies focusing on the complications
of OM, all the adult [older than 15 years (N=30)] and pediatric [15 years and younger (N=33)]
patients treated for intratemporal (ITC) or intracranial complications (ICC) of OM over the past
10 years (1990-2000) at the Department of Otorhinolaryngology in the Helsinki University Central
Hospital were included.
Results: A. otitidis was not detected by culture. PCR detected DNA of A. otitidis in 25% (30/118)
of the middle ear effusion (MEE) samples in AOM. The clinical outcome of the A. otitidis positive
children compared with the A. otitidis negative children did not differ in AOM. In OME, 20% (25/
123) of the MEE samples were positive for A. otitidis by PCR. A. otitidis positivity in PCR
correlated significantly with the long persistence and the mucoid appearance of MEE.
The annual age-adjusted incidence of acute intratemporal (ITC) and intracranial (ICC)
complications in children and adults was 1.1/100 000 and 0.3/100 000, respectively. Among the
children an ITC was found in 97% (32/33), and ICC in 3% (1/33). Among the adults, 73% (22/30)
had an ITC and 27% (8/30) had an ICC. Streptococcus pneumoniae (8/33) and Pseudomonas
aeruginosa (7/33) were the bacteria most frequently found in the MEE and mastoid effusions of
the children with ITC and ICC. Among the adults, S. pneumoniae (5/30) and Streptococcus
pyogenes (5/30) were the bacteria most often cultured. The signs of abscess forming ITC or ICC
were associated with performed mastoidectomy among both the pediatric and adult patients. All
children recovered completely. Among the adults, the complication of OM caused permanent
hearing loss in 30% (9/30) of the patients. One adult died from otogenic meningitis.
Conclusions: Our results suggest that A. otitidis has no clinical significance in AOM. In OME,
the existence of A. otitidis DNA correlates with the persistence of MEE. Severe complications of
OM are rare today. Among children these complications are usually intratemporal and present
with AOM, but among adults ICC and COM and cholesteatoma behind the complication should
be suspected more easily. In adults the clinical picture of ITC and ICC of OM is often slowly
progressing and mild. Antibiotics are the basis of the treatment and surgery should be considered
in abscess-forming ITC and ICC of OM.
9ABBREVIATIONS
AM acute mastoiditis
AOM acute otitis media
COM chronic otitis media
CRP C-reactive protein
CT computed tomography
DNA deoxyribonucleic acid
ICC intracranial complication
ITC intratemporal complication
ME mastoid effusion
MEE middle ear effusion
MRI magnetic resonance imaging
OM otitis media
OME otitis media with effusion
PBS phosphate buffered saline
PCR polymerase chain reaction
PTA pure tone average
RAOM recurrent acute otitis media
RNA ribonucleic acid
TM tympanic membrane
URI upper respiratory tract infection
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1 INTRODUCTION
Bacterial infection is considered the main
etiological factor of acute otitis media (AOM)
and acute complications of different types of
otitis media (OM) (Bluestone and Klein 2001).
Our knowledge about the bacteriology of OM
has changed markedly during the last 100 years
(Valentine 1924, Nielsen 1945, Kilpi et al.
2001), and, at the same time, there has been a
big change in the clinical presentation and
treatment of OM in developed countries (Kafka
1935, Lahikainen 1953, Juselius and
Kaltiokallio 1972, Palva et al. 1985). Some of
the bacterial species that caused middle ear
infections in the first half of the 20th century
are cultured today only rarely from the middle
ear effusions (MEE) in AOM (Valentine 1924,
Kilpi et al. 2001). On the other hand, some of
the bacteria that were earlier considered
harmless are now on the list of the most
commonly found pathogenic bacteria in AOM
(Jero et al. 1997, Kilpi et al. 2001). The
availability of penicillin and other antibiotics
since the 1950s divides the century into a pre-
antibiotic and antibiotic era, the two periods
with completely different problems with respect
to the treatment of OM (Lahikainen 1953,
Juselius and Kaltiokallio 1972).
During the last decades the most feared purulent
OM complications are encountered only rarely,
and the incidence of chronic OM complications
has been low (Palva et al. 1985). As a result,
clinical experience with the diagnosis and
treatment of these complications has decreased.
The use of antibiotics modifies the clinical
picture of OM and sometimes masks the
progression of infection leading to latent
complications (Faye-Lund 1989). The
worldwide increasing bacterial resistance to the
antibiotics used to treat OM points to the
importance of an accurate clinical and
bacteriological diagnosis of these infections.
The traditional bacterial diagnosis of OM is
based on the bacterial culture of MEE or
mastoid effusion (ME). With respect to AOM
the bacterial culture of MEE is still the gold
standard for identifying the possible bacterial
etiology of infection (Bluestone and Klein
2001). Today myringotomy is performed only
on patients with prolonged or otherwise
complicated OM. Many of these patients have
been treated with antibiotics before the MEE
sample has been obtained. In OM with effusion
(OME) the bacterial culture of MEE is more
often negative (Sipilä et al. 1981, Jero et al.
1996) suggesting low or no bacterial activity in
the middle ear. The detection of bacterial
deoxyribonucleic acid (DNA) by polymerase
chain reaction (PCR) could offer a new method
for the bacterial detection in OM (Post et al.
1995, Hendolin et al. 1999).
INTRODUCTION
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2.1 Acute otitis media
2.1.1 Definition
The definition of AOM has been discussed over
the years. The Research Conference in Fort
Lauderdale 1983 (Paparella et al. 1985) started
the development work that has provided
guidelines for the currently used definition.
AOM is an acute infection of the middle ear
cavity. The onset of signs and symptoms is
rapid. For the diagnosis of AOM, there must be
both acute ear-related local or systemic
symptoms and signs of MEE. Acute discharge
through a tympanic membrane perforation or
through a tympanostomy tube with signs of
acute infection is also considered AOM (Karma
et al. 1987, Rosenfeld and Bluestone 1999,
Bluestone and Klein 2001). The definition of
recurrent AOM (RAOM) has varied (Klein
1984, Alho et al. 1990). Many studies use the
criterion of 3 AOM episodes in 6 months or 4
episodes in 1 year (Klein 1984, Paradise 2002).
2.1.2 Epidemiology
The incidence of AOM is strongly age-related,
and AOM is one of the most common reasons
for antibiotic therapy in children (Paradise et
al. 1997). It is estimated that 500 000 cases of
AOM are diagnosed annually in Finland
(Niemelä et al. 1999). The peak incidence of
AOM occurs during the second half of the first
year of life. Thereafter the incidence of AOM
gradually decreases (Sipilä et al. 1987, Teele et
al. 1989, Alho et al. 1991). During the first year
of life, 42-62% of children experience at least
one episode of AOM (Teele et al. 1989, Alho et
al. 1991). By 2 years of age, up to 71% of
Finnish children have had at least one episode
of AOM (Alho et al. 1991). The incidence of
AOM has increased during the last few decades
in Finland (Joki-Erkkilä et al. 1998).
2.1.3 Pathogenesis
The etiology of AOM is multifactorial including
anatomical, infectious, immunological, genetic,
allergic, environmental and social factors
(Casselbrant et al. 2004, Bluestone and Klein
2001). Dysfunction of the eustachian tube and
impairment in the ventilation and clearance of
the middle ear are probably the most important
factors contributing to the development of AOM
(Stenfors et al. 1985, Casselbrant et al. 1988,
Buchman et al. 1995). The eustachian tube of
infants is more susceptible to functional
disturbances than the eustachian tube of older
children and adults (Bylander 1980, Sadler-
Kimes et al. 1989). This is one of the factors
explaining the decreasing incidence of AOM
with increasing age (Stenström et al. 1991).
An upper respiratory tract infection (URI)
usually starts the process leading to AOM and
symptoms of a URI are associated with AOM
in 94% of cases (Arola et al. 1990). Many recent
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studies have shown the important role of viruses
in the development of AOM, although the exact
mechanisms behind their action are still unclear
(Arola et al. 1990, Arruda et al. 1997, Pitkäranta
et al. 1998, Winther et al. 2002). Viruses, as a
sole pathogen, are found in 5% of MEE of AOM
by culture and antigen detection methods
(Chonmaitree et al. 1986, Heikkinen et al.
1999). Viral RNA is detected in 33-41% of MEE
of AOM by PCR in Finland (Nokso-Koivisto
et al. 2004). Viral infections induce mucosal
swelling in the nasopharynx and eustachian tube
leading to an impaired ventilation and clearance
of secretions from the middle ear (Buchman et
al. 1995, Bluestone 1996). This results in a
negative pressure and collection of effusion in
the middle ear. Viral infections also enhance
bacterial colonization and adherence in the
nasopharynx (Wadowsky et al. 1995, Hament
et al. 1999, Tong et al. 2000). It is suggested,
that the nasopharyngeal bacteria then ascend
via the eustachian tube into the middle ear to
cause the acute middle ear infection (Bluestone
and Klein 2001). In addition, viruses and
bacteria together induce an increased
production of inflammatory mediators in the
middle ear and they are probably responsible
for the clinical signs and symptoms of AOM
(Chonmaitree et al. 1996). Combined viral and
bacterial infection of the middle ear has also
been shown to lead to a decrease in the
antibiotic concentrations in the middle ear
(Jossart et al. 1994, Canafax et al. 1998).
2.1.4 Bacteriology
Bacteria are considered to be the major
etiological factor of AOM. The bacterial
etiology of AOM has been studied with the use
of MEE cultures and, during the last decade,
with PCR. Bacteria have been cultured in 67-
84% of MEE samples of AOM (Luotonen et al.
1981, Bluestone et al. 1992, Kilpi et al. 2001).
The three bacteria most frequently found in
MEE samples of AOM are Streptococcus
pneumoniae, Haemophilus influenzae and
Moraxella catarrhalis (Karma et al. 1987,
Bluestone et al. 1992, Kilpi et al. 2001). Less
frequently found bacteria are Streptococcus
pyogenes, Staphylococcus aureus, Chlamydia
trachomatis, coagulase-negative staphylococci,
and diphteroids (Chang et al. 1982, Bluestone
et al. 1992, Virolainen et al. 1994, Kilpi et al.
2001). The changing bacteriology of AOM is
presented in Figure 1. H. influenzae is isolated
significantly less often from MEE of AOM in
children over 3 years of age than in children
under 3 years of age (Luotonen et al. 1981).
Otherwise, the bacteriology of AOM seems to
be almost similar in different age groups
(Schwarz and Rodriguez 1981, Celin et al. 1991,
Kilpi et al. 2001, Turner et al. 2002), as well as
in different geographic areas of developed
countries (Bluestone et al. 1992, Leibovitz et
al. 1998, Commisso et al. 2000, Kilpi et al.
2001).
REVIEW OF THE LITERATURE
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Since the introduction of antibiotics, S.
pneumoniae has been the bacteria most
frequently found in MEE samples of AOM.
Today S. pneumoniae is found in 18-26% of
MEE specimens of AOM in Finland (Virolainen
et al. 1994, Kilpi et al. 2001), and in 16-50% in
other countries (Paraskaki et al. 1995,
Hoberman et al. 1996, Arguedas et al. 1998,
Sih 2001). Although more than 80 different
serotypes of S. pneumoniae exist, only some of
them are markedly associated with AOM. The
most frequently found serotypes are 19, 23, 6,
14 and 11 accounting for 78% of all AOM
caused by S. pneumoniae (Karma et al. 1987,
Kilpi et al. 2001). The rapidly increased
antibiotic resistance of S. pneumoniae has
increased the interest to this bacterium. In
Finland, 4-6% of S. pneumoniae strains are
penicillin resistant (Manninen et al. 1997, Kilpi
et al. 2001). However, in the United States, the
proportion of strains not susceptible to penicillin
ranges between 15% and 62% (Jacobs et al.
1999). In addition, the macrolide resistance of
S. pneumoniae is also increasing (Mason et al.
2003, Reinert et al. 2003). In Finland, 11% of
S. pneumoniae were resistant to erythromycin
in year 2000 compared with 5.3% in 1997
(Pihlajamäki et al. 2002). In the United States,
the proportion of macrolide resistant S.
pneumoniae is 20-30% (Jacobs and Johnson
2003).
H. influenzae was first mentioned as an AOM
pathogen in 1928 (Wirth 1928). Primarily
because of the difficulties to detect H.
influenzae in culture, it was not until 1945 that
this bacterium was more commonly accepted
as an etiologic factor in AOM (Nielsen 1945).
In those earlier days, H. influenzae was found
in 16% of the AOM effusions studied in Finland
Figure 1. Changing bacterial etiology of AOM.
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(Lahikainen 1953). In current studies the
corresponding incidence has ranged from 16%
to 23% (Jero et al. 1996, Kaijalainen et al. 2000)
and has been shown to be 7-40% in other
countries (Bluestone et al. 1992, Gehanno et
al. 2001, Sih 2001). Today, almost all H.
influenzae positive cases of AOM are caused
by nontypable strains. In a recent study in
Finland, 14% of the H. influenzae strains
causing AOM produced beta-lactamase (Kilpi
et al. 2001).
During the last 20 years, the proportion of M.
catarrhalis (former Branhamella catarrhalis)
positive effusions in AOM has increased
markedly. Before the 1980s, M. catarrhalis was
generally considered an innocent and
nonpathogenic bacterium. In 1981 serologic
evidence of the pathogenic role of M.
catarrhalis in AOM was introduced  (Leinonen
et al. 1981). Then in 1983 two different groups
reported a significant increase in the incidence
of M. catarrhalis in the MEE of pediatric
patients with AOM in the United States
(Kovatch et al.1983, Shurin et al. 1983). In the
study of Shurin et al. (1983), the incidence of
M. catarrhalis increased from 6% to 27%
between 1979 and 1982. Recent studies have
shown geographic differences in the incidence
(1-23%) of M. catarrhalis in AOM (Commisso
et al. 2000, Gehanno et al. 2001, Sih 2001, Kilpi
et al. 2001). Low incidence of M. catarrhalis
in AOM has been reported from Brazil and
Argentina (Sih 2001, Commisso et al. 2000).
In Finland, M. catarrhalis has been cultured in
9-23% of the MEE specimens of AOM ( Jero
et al. 1996, Kilpi et al. 2001). Today over 90%
of the M. catarrhalis strains isolated from MEE
specimens of AOM produce beta-lactamase
(Kilpi et al. 2001).
In the pre-antibiotic era S. pyogenes was the
bacterium most frequently found in MEE
specimens of AOM, especially in cases with
scarlatina or acute tonsillitis (Valentine 1924,
Nielsen 1945). However, the use of penicillin
in the treatment of these diseases has decreased
the incidence of S. pyogenes, and today it is
found only rarely in the MEE of AOM (Jero et
al. 1997, Kilpi et al. 2001). S. aureus is an
uncommon cause of AOM, and it is found in
less than 5% of MEE samples in AOM
(Bluestone et al. 1992, Jero et al. 1997). Low
numbers of coagulase-negative staphylococci
and diphtheroids are found in AOM, but their
role is uncertain and they are often considered
to be nonpathogenic commensals or
contaminants from the ear canal (Bluestone and
Klein 2001). Alloiococcus otitidis is a Gram-
positive coccus found in MEE samples of OME
(Faden and Dryja 1989). It is suggested that it
might be a potential middle ear pathogen in
OME (Faden and Dryja 1989, Bosley et al.
1995). However, there are no reports of A.
otitidis in AOM.
In studies of AOM there is always a significant
number of culture-negative MEE specimens.
In recent studies in Finland, it has been 17-22%
(Virolainen et al. 1994, Kilpi et al. 2001).
However, the finding that culture negative MEE
specimens of AOM contain polymorphonuclear
leukocytes or pneumococcal antigens and
antibodies suggests a bacterial cause also in
these episodes (Karma et al. 1987, Broides et
al. 2002). Many different factors can be related
REVIEW OF THE LITERATURE
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to culture-negative MEE specimens in AOM.
The microbial etiology can be nonbacterial, or
the bacteria can be fastidious and difficult to
culture. Antibiotic treatment prior to the sample
collection and the possible presence of
antimicrobial enzymes or immunoglobulins in
MEE may suppress the growth of bacteria
(Bluestone and Klein 2001).
PCR identification of bacteria in OM is based
on the amplification and detection of bacterial
DNA from MEE (Mullis and Faloona 1987,
Saiki et al. 1988). In PCR, a double-stranded
DNA is first denatured by heat, and, when the
temperature is lowered, the primers anneal to
the separated strands at the boundaries of the
target region. Then DNA polymerase enzyme
extends the primer-template complex to
produce new complementary strands. When
these steps are repeated, the target DNA
sequence is amplified exponentially. The
amplification product is then detected, for
example, by agarose gel electrophoresis or
Southern blotting.
PCR is an extremely sensitive method for
detecting bacterial DNA. PCR has been used
widely for the detection of bacteria in MEEs.
However, controversy exists about the clinical
relevance of detecting bacterial DNA in MEE.
It has been proposed that bacterial DNA in MEE
could be a remnant of a previously cleared
infection (Cantekin 1996) rather than an
indication of viable bacteria in the MEE.
Peizhong et al. (2000) showed that MEE is able
to inhibit DNA nuclease and the normal
breakdown of bacterial DNA in MEE. They
concluded that DNA detected by PCR might
represent a remnant of non-viable bacteria
rather than ongoing infection. However, it has
been shown in the chinchilla model of OM that
bacterial DNA from non-viable bacteria does
not remain amplifiable in MEE longer than a
day (Post et al. 1996, Aul et al.1998). Later, it
was shown that the majority (81.5%) of MEE
samples that contained endotoxin were positive
for the gram-negative bacteria H. influenzae and
M.catarrhalis by PCR (Dingman et al. 1998).
The authors concluded that the source of
endotoxin is viable, but nonculturable bacteria
present in the MEE. Rayner et al. (1998)
detected, in addition to H. influenzae genomic
DNA, messenger ribonucleic acid (mRNA) of
the constitutive gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).
Messenger RNA has a short half-life, and it
would confirm the presence of viable bacteria
in MEE. Of 93 MEE samples of OME, only 11
(11.3%) were positive by culture, whereas 29
(31.5%) tested positive for genomic DNA. All
of these PCR-positive samples were also
positive for mRNA, an indication of bacterial
metabolic activity for H. influenzae. Palmu et
al. (2004) studied 2595 MEE samples of AOM
by PCR and compared the results with the
results of pneumococcal culture. PCR was
positive for 1222 (47.1%) of the MEE samples.
In bacterial culture, 709 (27.3%) of the MEE
samples were positive for S. pneumoniae. A
culture-negative and PCR-positive MEE was
often related to a clinically milder infection,
compared with S. pneumoniae culture-positive
AOM. A positive PCR seemed to indicate the
presence of viable, but non-culturable S.
pneumoniae  in MEE.
REVIEW OF THE LITERATURE
17
The sensitivity and specificity of PCR to
indicate pneumococcal involvement in MEE of
AOM has varied. Virolainen et al. (1994)
studied 180 MEE samples of AOM and
compared the results of bacterial culture with
those of pneumolysin-specific PCR for S.
pneumoniae. In culture S. pneumoniae was
found in 33 (18%) samples, but with PCR it
was detected in 51 (28%) MEE samples.
However, three of the S. pneumoniae culture-
positive MEE samples were negative for PCR.
Saukkoriipi et al. (2002) used a real-time
quantitative PCR to detect S. pneumoniae in
50 MEE specimens from children with AOM.
Real-time PCR was positive in 26 samples,
whereas only 17 samples yielded positive result
by culture. The sensitivity and specificity of
real-time PCR, when compared with culture
were 100% and 73%, respectively.
2.1.5 Clinical picture and diagnosis
The clinical picture of AOM varies. Most
patients with AOM have viral URI, and many
of the acute symptoms of AOM are the same as
those of viral URI (e.g., rhinitis, cough, fever,
gastrointestinal symptoms, loss of apetite,
irritability or restless sleep). Fever as a single
symptom is found in 23-60% of children with
AOM and in 28-77% of children with URI
without AOM (Schwartz et al. 1981, Niemelä
et al. 1994, Heikkinen and Ruuskanen 1995,
Kontiokari et al. 1998). Ninety percent of
children with AOM have a fever or an earache,
whereas 72% of the children with URI without
AOM have these same symptoms (Niemelä et
al. 1994).
Earache and other ear-related symptoms
(rubbing or pulling the ear, feeling of ear-block)
are the most common complaints of children
with AOM, and at least one of these is found in
59-78% of children with AOM (Niemelä et al.
1994, Heikkinen and Ruuskanen 1995,
Kontiokari et al.1998). Children younger than
2 years often cannot express their ear
symptoms, and the only symptoms indicating
AOM may be irritability and restlessness. Ear
pulling is a common sign in infants, but without
concomitant URI it does not indicate AOM
(Baker 1992). In the study of Niemelä et al.
(1994) two-thirds of the children under 2 years
of age had AOM-associated ear-related
symptoms. However, if restlessness, irritability
and ear symptoms all are included, these
symptoms are found in 83% of children
(Hayden and Schwartz 1985). It should also be
remembered that earache does not always
indicate a middle ear problem. Other possible
sources of ear pain are lesions in the nerve
supply area of the trigeminal, facial,
glossopharyngeal, vagus, great auricular or
lesser occipital nerve (e.g., tonsillitis,
pharyngitis or external otitis) (Bluestone and
Klein 2001). On the other hand, about one-third
of the children under 2 years of age with AOM
have no ear-related symptoms (Niemelä et al.
1994).
Hearing loss, tinnitus and vertigo are also
possible signs of AOM. Older children are
capable of verbalizing the loss of hearing, but,
with younger children, the loss of function is
often expressed by parents as a suspicion of
hearing loss. Vertigo and tinnitus are sometimes
associated with AOM, and they are usually due
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to eustachian tube dysfunction. However,
vertigo can also be associated with nystagmus
and be a sign of complicated AOM with
labyrinthitis (Bluestone and Klein 2001).
In physical examination the possible conditions
predisposing to OM should be noted. Genetic
and developmental disturbances, such as the
Treacher Collins syndrome and Down
syndrome, are associated with an increased
incidence of middle ear infections. Cleft palate
with its variations and bifid uvula also involve
an increased risk of OM (Stool and Randall
1967, Paradise et al. 1969, Taylor 1972). Nasal
and nasopharyngeal pathology (e.g., sinonasal
infections, polyposis and tumors) should be
excluded (Bluestone and Klein 2001).
Because there is no single symptom or
combination of symptoms specific for AOM,
its diagnosis can only be verified by the
detection of MEE. The examination of the
auricle, the periauricular area and the external
auditory canal is important for differential
diagnostic purposes and for the recognition of
possible complications of OM. Pneumatic
otoscopy is used to examine the appearance,
position, and mobility of the TM. The most
reliable signs of AOM with respect to the TM
are cloudiness or a yellow color, a bulging
position, and impaired mobility (Karma et al.
1989, Arola et al. 1990). A common finding for
the TM is redness, but it is found in less than
half of the children with AOM (Arola et al.
1990). Thus, redness of the TM as a single
finding does not confirm the diagnosis of AOM
(Karma et al. 1989). It should also be
remembered that a small proportion (1-5%) of
children with AOM have a TM that is normal
in color or mobility (Karma et al. 1989).
Otoscopy is also a very subjective examination.
Its accuracy is highly dependent on the
observer´s experience. Correctly performed
pneumatic otoscopy is a reliably diagnostic tool
(Karma et al. 1989, Jones and Kaleida 2003).
Still, tympanocentesis (needle aspiration of
MEE) or myringotomy (incision of the TM) are
the only direct methods with which the presence
of MEE can be verified. One of these should
be used when a bacterial diagnosis of MEE is
needed or there are signs of complications of
AOM (Bluestone and Klein 2001). However,
myringotomy does not seem to improve the
recovery from AOM (Puhakka et al. 1999).
All the aforementioned clinical signs and
symptoms of AOM are subjective, and
therefore, the risk of a false diagnosis always
exists. Tympanometry is an objective diagnostic
tool for measuring middle ear pressure, the
presence of MEE, and TM mobility. The result
of tympanometry is highly dependent on the
patient´s cooperation. With cooperative patients
its specificity is over 90%, and its sensitivity is
about 80% (Koivunen et al. 1997). However,
with non-cooperative patients the sensitivity
falls to 71% and the specificity to 38%. In
addition, with non-cooperative patients,
tympanometry is often technically impossible
to perform adequately (Koivunen et al. 1997,
Palmu et al. 1999). Nevertheless, when these
limitations are kept in mind, tympanometry is
a useful aid in the diagnosis of AOM. Acoustic
reflectometry offers an alternative way to study
the presence of MEE objectively. It was
introduced in 1984 (Teele and Teele 1984). The
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main advantage of acoustic reflectometry, when
compared with tympanometry, is that an air-
proof ear seal for pressurization is not required,
and it is less technique-dependent than
tympanometry. Therefore, the measurement can
be done even when the cooperation of the
patient is not optimal. The sensitivity and
specificity of acoustic reflectometry and
tympanometry seem to be almost the same
(Block et al. 1998). Acoustic reflectometry has
also proved to indicate MEE in AOM accurately
(Block et al. 1999), but the diagnosis of AOM
always demands both a clinical picture of AOM
and the detection of MEE.
2.1.6 Treatment
Today the treatment of AOM in Finland is based
on the use of antibiotics and symptom-reliving
medication. Because, in 69-86% of cases
(Mygind et al. 1981, Burke et al. 1991), AOM
resolves spontaneously, watchful waiting is an
alternative to antibiotics. In Finland,
tympanocentesis, myringotomy, and surgical
treatment are used in complicated cases or when
the microbial etiology of AOM should be
confirmed (Puhakka et al. 1999).
In pre-antibiotic era, waiting and myringotomy
were the only treatment options for AOM. The
introduction of sulfonamides in the 1930s and
penicillin in the 1940s radically changed the
clinical picture of AOM. The report of
Lahikainen (1953) shows the dramatic effect
of antibiotics on the outcome of AOM. In a
material of 629 patients, 176 were given
penicillin and 453 were treated without
antibiotics. In the group treated with antibiotic,
there were no complications of AOM. In
contrast, in the group treated without
antibiotics, the following intratemporal (ITC)
or intracranial (ICC) complications occured: 7
cases of mastoiditis, 1 case of meningitis and 1
fatal case of sinus thrombosis with an associated
brain abscess. The morbidity and mortality
associated with AOM has been shown to decline
significantly and the recovery from AOM is
shorter when accurate antibiotic treatment is
used (Nielsen 1945, Lahikainen 1953, Rudberg
1954, Tarkkanen and Kohonen 1970). In
addition, complicated AOM cases in association
with S. pyogenes positive tonsillitis and
scarlatina have almost disappeared. These
tremendous results have justified the use of
antibiotics for AOM.
During the last few decades bacterial resistance
to antibiotics has increased worldwide. As a
result the question of a rational use of antibiotics
in the treatment of AOM, has become
important. Several studies have shown some
positive effect of antibiotic treatment in the
resolution of AOM, although, in most children,
symptoms and MEE resolve spontaneously
even without antibiotic treatment (Van Buchem
et al. 1981, Kaleida et al. 1991, Burke et al.
1991, Damoiseaux et al. 2000). Two large meta-
analyses also showed that antibiotics may
improve the relief of symptoms and signs of
AOM, but the effect is modest (Rosenfeld et
al. 1994, Del Mar et al. 1997). It has been
calculated, that 25 children must receive
antibiotics to relieve symptoms of AOM in one
child in 2-3 days (Rosenfeld and Bluestone
1999). It is also estimated, that seven children
should be treated with antibiotics for one
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complete clinical resolution of AOM within 7-
14 days. Although we know some prognostic
factors for AOM (e.g., age<2 years, allergic
symptoms, long duration of pretreatment
earache, M. catarrhalis in MEE) (Jero et al.
1997, Monobe et al. 2003), we still do not have
the prognostic tools needed to tell us who will
benefit from antibiotic treatment and who will
recover spontaneously. In the Netherlands,
AOM in children is usually managed with initial
observation and only the patients with
complications of AOM are treated with
antibiotics (Van Zuijlen et al. 2001). In Finland,
it is recommended that antibiotic treatment
should be started when AOM is diagnosed
(Puhakka et al. 1999). If antibiotic treatment is
not started, the patient should be examined
again after 1-2 days (Puhakka et al. 1999).
In Finland, the recommended first-choice
antibiotic for AOM has been either penicillin-
V or amoxicillin (Puhakka et al. 1999). In the
United States amoxicillin 40mg/kg aday is the
drug of choice (Dowell et al. 1999), and
doubling the dosage to 80mg/kg aday has
proved effective for intermediate non-
susceptible S. pneumoniae (Seikel et al. 1997).
Today in Finland, the incidence of H. influenzae
and M. catarrhalis in MEE of AOM is almost
equal to that of S. pneumoniae (Kilpi et al.
2001). If antibiotic treatment is started to
resolve an infection in the middle ear, the
increased number of H. influenzae and M.
catarrhalis positive AOM should also be taken
into consideration when the antibiotic is chosen.
Because S. pneumoniae is the pathogen least
likely to resolve spontaneously in AOM
(McCracken 1994, McCracken 1999) penicillin
or amoxicillin is chosen. In Finland, over 90%
of the M. catarrhalis and 10-20% of the H.
influenzae strains produce beta-lactamase and
pneumococcal resistance to penicillin is 4%
(Kilpi et al. 2001). As a result, in 20-30% of
the AOM cases there are penicillin non-
susceptible bacteria. If treatment with
amoxicillin fails, the recommendation is
amoxicillin-clavulanate, or, when the patient is
allergic to beta-lactam antibiotics,
trimethoprim-sulfa or a macrolide
(azithromycin, clarithromycin) is used
(Leibovitz et al. 1998, Dowell et al. 1999). In
the recent report of Block et al. (2001) treatment
with one of the 3rd generation oral
cephalosporins, cefdinir or cefpodoxime, was
suggested when aminopenicillins failed to cure
a middle ear infection. Most bacteriological
relapses of AOM occur within 2 weeks after
the end of an antibiotic treatment, and AOM
that recurs 2 weeks to 1 month after a finished
antibiotic treatment is usually a new infection
(Leibovitz et al. 2003). This difference should
be taken into consideration when an antibiotic
treatment is chosen. If the medication cannot
be administered orally, a single-dose
intramuscular ceftriaxone is a possible
treatment alternative (Green and Rothrock
1993, Barnett et al. 1997).
Symptom relieving medication is often used to
treat patients with AOM. Analgesics should be
used during the first days of AOM to achieve
pain relief, but they have no curative effect on
middle ear infections (Varsano et al. 1989).
Nasal decongestants and antihistamines are
widely used to reduce congestion of the mucosa
of the eustachian tube and to shorten the
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duration of MEE. However, the efficacy of these
medications in AOM has not been demonstrated
in randomized and placebo-controlled studies
(Flynn et al. 2004). The duration of MEE can
be even longer with antihistamine treatment
than without such a medication (Chonmaitree
et al. 2003).
Myringotomy was first introduced in 1802
(Alberti 1974) and has since been used in the
treatment of OM. The potential benefits
achieved with myringotomy are a relief of
earache, a possibility to obtain etiological
samples, and a decrease in the number of cases
with persisting MEE and RAOM. The
randomized trials that have been published
concerning the efficacy of myringotomy in the
treatment of AOM (Lorentzen and Haugsten
1977, Van Buchem et al. 1981, Van Buchem et
al. 1985, Engelhard et al. 1989, Kaleida et al.
1991) have however, not shown statistically
significant differences in the clinical outcome
of patients receiving and not receiving
myringotomy. Therefore, myringotomy is not
a routine treatment of AOM and should be
reserved for complicated cases (RAOM, ITC
and ICC) to identify bacterial etiology of the
disease. When a patient has severe otalgia,
myringotomy may offer pain relief and thus can
be used in selected cases as a symptomatic
treatment (Puhakka et al. 1999, Bluestone and
Klein 2001).
Tympanostomy tube insertion is widely used
in the treatment of RAOM, and it is the most
common surgical procedure performed in
children in general anesthesia. The idea of using
tympanostomy tubes dates back to the 19th
century (Alberti 1974), but tubes were
reintroduced in the 1950s (Armstrong 1954).
Tympanostomy tube insertion is effective in the
treatment of RAOM (Gebhart 1981, Gonzalez
et al. 1986, Casselbrant et al. 1992).
Casselbrandt et al. (1992) randomized 264
children who were between 7 and 35 months
of age and who had had recurrent episodes of
AOM into three groups: amoxicillin
prophylaxis, myringotomy and tube insertion,
and placebo. Although there was no difference
in the number of AOM episodes between the
tympanostomy and placebo groups, the overall
time with AOM was 6.6% in the tympanostomy
group in a comparison with 15.0% in the
placebo group (P<0.001). In addition, in the
tympanostomy group, the periods with otorrhea
were usually otherwise asymptomatic and less
troublesome than AOM episodes in the
amoxicillin or placebo groups. Tympanostomy
tube insertion is considered a safe procedure
even in young children (Valtonen et al. 1999).
It is recommended as the first choice of
operative treatment in cases of RAOM when
antimicrobial prophylaxis fails (Bluestone and
Klein 2001).
The role of adenoidectomy in the treatment of
RAOM has caused wide debate over the years.
However, only a few well-designed randomized
studies have dealt with this topic. Paradise et
al. (1999) found modest, short-term
improvement in the outcome of children over
3 years of age with RAOM when
adenoidectomy was the first operative
treatment. However, among children with
RAOM who had been previously treated with
tympanostomy tubes, adenoidectomy seems to
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reduce the time with AOM and the number of
suppurative AOM episodes (Paradise et al.
1990). Mattila et al. (2003) compared the effect
of tympanostomy tube insertion alone with
tympanostomy tube insertion combined with
adenoidectomy among children of 1 to 2 years
of age with RAOM. They found no marked
difference in the rate of further AOM episodes
between the two groups. In a recently published
randomised study, the effect of adenoidectomy,
chemoprophylaxis, and a placebo were
compared as a treatment of RAOM in children
less than 2 years of age with no significant
differences in the outcome between the groups
(Koivunen et al. 2004). Thus, adenoidectomy
does not seem to be the primary operative
treatment for RAOM, but children with RAOM
older than 3 years may benefit from this
operation.
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2.2 Otitis media with effusion
2.2.1 Definition
OME is defined as a relatively asymptomatic
effusion in the middle ear (Bluestone and Klein
2001, Lim et al. 2002). The previously widely
used terms serous, secretory, or nonsuppurative
otitis media are all included in this definition.
The effusion can be serous, mucoid, or even
purulent, but, in OME, there are no clinical signs
or symptoms of acute infection. This definition
gives no time limits for the duration of MEE,
but the following classification is
recommended: acute (less than 3 weeks),
subacute (3 weeks to 3 months), and chronic
(longer than 3 months). According to otoscopic
findings, tympanometric patterns or hearing
thresholds, OME can be classified as mild,
moderate or severe (Table 1) (Bluestone and
Klein 2001). OME is manifest as a conductive
hearing loss in the affected ear. In pneumatic
otoscopy the TM is often retracted, and its
mobility is impaired. If the TM is translucent,
the air-fluid level or bubbles can be seen in the
middle ear. However, in OME, opacification of
the TM is a frequent finding, and the evaluation
of the type of MEE is not always possible by
otoscopy.
Table 1. Classification of OME according to otoscopic appearance, tympanometric pattern and
hearing thresholds
                               Mild      Moderat         Severe
Otoscopy
Tympanometry
Hearing threshold Unilateral disease,
better than 20dB
in both ears
Bilateral disease,
better than 20 dB
in the better-hearing ear
TM: retracted, mobile,
translucent, air-fluid level
or bubbles
TM: retracted, immobile,
clouded, possible
air-fluid level or bubbles
TM: retracted,
immobile,
completely opaque
Negative pressure,
normal compliance Low compliance
Bilateral disease,
worse than 20dB
in both ears
Low compliance
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2.2.2 Epidemiology
OME is, in most cases, a continuum of AOM,
and therefore the prevalence and risk factors
of OME are closely bound to those of AOM.
Teele et al. (1980) showed that, after the first
attack of AOM in infants, 10% develop chronic
OME (over 3 months). In a small proportion of
cases, OME develops spontaneously because
of the poor functioning eustachian tube. OME
does not produce acute symptoms, and
therefore it is difficult to estimate its real
prevalence. The reported prevalence rates of
OME vary widely and are highly age dependent.
The highest prevalence of OME occurs between
6 months and 4 years of age, showing a peak
around one year of age (Marchant et al. 1984,
Paradise et al. 1997, American Academy of
Pediatrics 2004). More than 50% of children
suffer from OME during the first year of life.
This proportion will rise to over 60% during
the second year (Casselbrant et al. 1985,
American Academy of Pediatrics 2004).
Casselbrant et al. (1985) showed that most
OME episodes (80%) resolve spontaneously
among preschool children within 2 months.
They also showed that the variation in the
prevalence of OME was associated with the
presence of URI and the season. In a recent
study from Turkey, Okur et al. (2004) reported
an overall prevalence of 6.5% for children
between 6 and 16 years of age. In Finland, Alho
et al. (1995) in a birth cohort with a 2-year
follow-up reported a 4% prevalence of OME
for children less than 2 years of age with the
peak incidence occurring between 10 to 16
months of age. A decreasing prevalence of OME
with an increasing age has been reported in
many studies (Daly 1994, Apostolopoulos et al.
1998, Marchisio et al. 1998).
2.2.3 Pathogenesis
The pathogenesis of OME probably involves
most of the same mechanisms as AOM.
Although OME often seems to be a continuum
of AOM, bacterial growth is found significantly
more rarely in the MEE of OME than in that of
AOM (Krenke et al. 1988, Giebink 1989). In
OME, metaplasia of the middle-ear epithelium
with a growing number of mucosal goblet cells
leads to the increasing production of mucoid
MEE (Ishii et al. 1980, Tos 1980). Mucin
production exceeds the mucociliary clearence
and causes an accumulation of fluid in the
middle-ear cavity. The excessive production and
accumulation of fluid in OME is thought to be
the result of a residual inflammation after AOM
and ineffective pressure control because of tubal
dysfunction (Rovers et al. 2004). It has also
been proposed that OME and active mucin
production in the middle ear could be a natural
defensive response of the body against chronic
infection, for example, in mucosal biofilm in
the middle ear (Ehrlich et al. 2002, Post 2003,
Fergie et al. 2004). Many aspects support this
assumption. MEE in OME has chemical
properties that help to protect against
microorganisms. Mucus contains, for example,
lysozyme, immunoglobulins, complement
components, antimicrobial peptides, cytokines
and leukotrienes, all components that can be
considered a part of an antimicrobial barrier in
the middle ear. Eustachian tube dysfunction can
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also be considered merely as a result of an
infective process rather than as a mechanical
obstruction (de Rue and Grote 2004).
2.2.4 Bacteriology
For a long time OME was considered a sterile
condition, and the rare positive bacterial
cultures of MEE in OME were considered
contamination (Hoople 1950, King 1953). In
1958 Senturia et al. published the results of their
study concerning tubotympanitis. They reported
bacterial growth in half of the 70 mucopurulent
or mucoid middle-ear specimens studied. Since
then numerous studies have been carried out
on the bacteriology of OME. Liu et al. (1975)
studied 100 patients with chronic MEE and
found bacterial growth in 52 % of the samples.
The three most prevalent organisms found were
diphtheroids, Staphylococcus epidermidis and
H. influenzae. They also recognized that the
bacterial recovery rate decreased with
increasing age. Healy and Teele (1977)
examined 57 patients with OME and found
bacterial growth in 46% of the obtained MEE
specimens. The most frequently found bacteria
were S. epidermidis, S. pneumoniae and H.
influenzae. In the MEE of the children under 3
years of age the bacterial flora resembled that
of AOM. This finding has also been recently
confirmed by Brook et al. (2001). Bacteria
found from MEE of OME often have an
increased resistance to antimicrobial agents.
Haddad et al. (2000) found that over half
(52.2%) of S. pneumoniae isolates identified
from the MEE of children with OME were not
susceptible to penicillin. Brook et al. (2003)
studied 129 children with OME and found
bacterial growth in the MEE of 58 patients. In
71% of the specimens, the bacterium cultured
was resistant to the used antibiotic. The authors
suggest that antibiotic resistant pathogens may
have an important role in the persistence of
OME.
The results of bacterial cultures in different
reports have varied. Figure 2 summarizes the
proportions of the most important middle ear
pathogens in bacterial cultures of OME in seven
selected studies. According to these
publications the incidence of bacterial growth
in the MEE of OME varies between 21% and
70%. However, negative bacterial cultures have
also been reported for OME even with modern
culture methods (Saffer et al. 1996). The most
frequently found pathogens in OME are the
same as found in AOM i.e., S. pneumoniae, H.
influenzae and M. catarrhalis, with the
incidence of 3% to 16%, 4% to 22% and 1% to
10%, respectively. Altogether the three
pathogens were found in these selected studies
in 8% to 32%.  The incidence of S. aureus in
OME has been from 0% to 10%. S. pyogenes is
found only occasionally in OME (<1%). S.
epidermidis and other coagulase-negative
staphylococci are the most frequently reported
findings concerning OME. They are mostly
considered contaminants, although
Staphylococcus epidermidis has sometimes
been proposed as a possible middle ear
pathogen (Bernstein et al. 1982, Soriano 1997).
Another widely found group of bacteria in OME
are diphtheroids or coryneform bacteria. Two
of these have been suggested as possible
middle-ear pathogens, namely Turicella otitidis
(Funke et al. 1993, Simonet et al. 1993, Funke
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Figure 2. Comparison of incidences of the three most important middle ear pathogens in
bacterial cultures from the MEE of OME in seven selected studies.
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et al. 1994) and Corynebacterium auris (Funke
et al. 1995). Holzmann et al. (2002) reported
that both T. otitidis and Corynebacterium auris
are part of the normal bacterial flora of the
external ear canal, and they proposed that these
two bacteria are probably not involved in the
pathogenesis of OME. However, T.otitidis has
been cultured in a pure culture of a MEE sample
from a patient with acute mastoiditis (AM)
(Dana et al. 2001), and therefore the true role
of T. otitidis in the pathogenesis of OM still
remains open. Currently anaerobic bacteria
seem to play a minor role in the pathogenesis
of OME (Bluestone and Klein 2001).
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Table 2. PCR in the bacteriological diagnosis of OME
During the last decade, several studies have
been carried out to determine whether PCR
could be used in the detection of middle ear
pathogens in OME. The results of seven
selected studies are summarized in Table 2. The
main interest in this field of research has been
the three clinically most important bacteria, S.
pneumoniae, H. influenzae and M. catarrhalis.
However, few studies have been carried out with
the intention of more comprehensively settling
the question concerning the bacterial load of
MEE in OME (Post et al. 1996, Hendolin et al.
1999). The overall rate of PCR-positive
effusions from patients with OME has varied
Study (n=number of specimens) Bacterium     PCR positive N(%)    Culture positive N(%)
Hotomi et al. 1993 (n=27) H. influenzae  15(55.6)    0(0)
Post et al. 1995 (n=97) S. pneumoniae  29(29.9)   5(5.2)
H. influenzae  53(54.6)  21(21.6)
M.catarrhalis  45(46.4)    5(5.2)
Jero et al. 1996 (n=123) S. pneumoniae  57(46.3)  14(11.4)
Hendolin et al. 1997 (n=25) S. pneumoniae    2(8)    2(8)
H. influenzae  13(52)    2(8)
M. catarrhalis    4(16)    4(16)
A. otitidis    5(20)    0(0)
Hendolin et al. 1999 (n=67) S. pneumoniae  14(20.9)   2(3.0)
H. influenzae  12(17.9)   6(9.0)
M. catarrhalis  25(37.3)   6(9.0)
A. otitidis  31(46.3)    0(0)
Beswick et al. 1999 (n=12) Universal  12(100)  2(16.7)
Gok et al. 2001 (n=37) S. pneumoniae    8(21.6)   5(13.5)
H. influenzae  11(29.7)   2(5.4)
M. catarrhalis    1(2.7)    0(0)
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from 46% to 100%. S. pneumoniae has been
detected in 8% to 46.3% of the MEE samples
in cases of OME. The incidence of H.
influenzae in OME has varied from 17.9% to
55.6%, and, in most studies, it has been the most
frequently found OM pathogen. The recovery
rate of M. catarrhalis has ranged from 2.7% to
46.4% for the MEE of OME. In their study
Beswick et al. (1999) used a universal primer
targeting all bacteria. Their results differ from
those of all other studies. In their material of
12 patients growth occurred in the bacterial
culture in only 2 (16.7%) samples, both
coagulase-negative staphylococci. However,
with PCR all the samples were positive for one
to five different bacterial species, which were
mostly regarded as opportunists. In all these
studies, PCR increased the detection rate of
bacteria significantly. PCR proved also to be a
specific method for detecting bacterial DNA in
MEE.
A. otitidis is a bacterium first found in MEE
samples of OME. Faden and Dryja (1989) were
the first to report the recovery of a new, possible
middle ear pathogen from the MEE of OME.
Aguirre and Collins (1992) studied the
biochemical properties of this bacterium and,
according to a 16S rRNA gene analysis,
proposed that it represented a new genus. They
named it Alloiococcus otitis, but the bacterium
was later renamed Alloiococcus otitidis (von
Graevenitz 1993). It is a fastidious and slowly
growing, strictly aerobic gram-positive
diplococcus, with special growth requirements
(Bosley et al. 1995, Faden and Dryja 1989). It
has been cultured in heart-infusion agar plates
supplemented with rabbit blood (Bosley et al.
1995, Miller et al. 1996). In bacterial cultures
of MEE from OME the recovery rate of A.
otitidis has been 0% to 5% (Faden and Dryja
1989, Sih et al. 1992, Hendolin et al. 1999).
There are no reports of A. otitidis in bacterial
cultures of AOM. With PCR, A. otitidis has been
detected in 10% to 50% of the MEE samples
of OME (Beswick et al. 1999, Hendolin et al.
1999, Hendolin et al. 2000, Kalcioglu et al.
2002). The presence of A. otitidis in a pure
culture, and its occasional intracellular location,
has raised the question of a possible pathogenic
role in OME (Faden and Dryja 1989, Bosley et
al. 1995).  There are no reports about the
possible pathogenic role of A. otitidis in other
localizations. Durmaz et al. (2002) found A.
otitidis DNA in nasopharyngeal and external
ear canal swabs and proposed that these canals
could be the localization sites for A. otitidis.
Only one report about the antibiotic resistance
of A. otitidis has been published (Bosley et al.
1995). The A. otitidis isolates studied were
either susceptible or intermediately resistant to
penicillin and ampicillin. All of the isolates were
beta-lactamase negative. All strains were
resistant to trimethoprime-sulfamethoxazole
and, except for one strain, to erythromycin.
2.2.5 Clinical picture and diagnosis
According to the definition of OME, patients
with this disease are almost asymptomatic.
Chronic MEE is often a consequence of AOM
and can be diagnosed during a follow-up.
Because of chronic MEE, parents´ suspicion of
or patients´ own complaints of hearing loss are
common. Occasionally vertigo and tinnitus are
encountered. For some children, OME is
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diagnosed when a child is examined because
of a developmental delay in speech and
language. Sometimes difficulties in hearing and
communication may lead to behavioral
problems. OME can also be found during a
routine examination without previously
diagnosed AOM and any knowledge of the
duration of MEE (Bluestone and Klein 2001).
In the clinical examination pneumatic otoscopy
is the primary tool used to diagnose OME. The
diagnosis of OME is based on the presence of
MEE and the lack of symptoms of acute
infection. Pneumatic otoscopy shows the best
balance between sensitivity and specificity in
the diagnosis of OME. The sensitivity of
pneumatic otoscopy is reported to be 94%, and
the specificity 80%, for validated observers
when the results are compared with those of
myringotomy. The true value of pneumatic
otoscopy in clinical practice is dependent of the
clinicians´ experience in using it and in their
ability to evaluate the findings (Pichichero and
Poole 2001). Tympanometry and acoustic
reflectometry can be used to increase diagnostic
accuracy and to confirm the diagnosis of OME
(American Academy of Pediatrics 2004).
Audiometric evaluation is recommended in
OME when the duration of MEE exceeds 3
months or if there is any suspicion of significant
hearing loss or if a delay in speech and language
is noted. Hearing testing can be done in primary
care for children 4 years of age and older.
Children who are under 4 years of age, fail
primary care testing, or cannot be tested in
primary care should be tested more
comprehensively (Joint Committee on Infant
Hearing 2000). In reports concerning hearing
loss in OME, the pure tone average (PTA) (500,
1000, 2000 Hz) has ranged from 0 to 55 dB
(Fria et al. 1985, Kokko 1974). Evidence shows
that OME with long duration of MEE and
significant hearing loss may have
developmental consequences (Friel-Patti and
Finitzo 1990, Gravel et al. 1995). However, the
recent meta-analysis by Roberts et al. (2004)
found only a slight association between OME
and the development of speech and language.
OME has a tendency towards significant
spontaneous resolution. The resolution of MEE
in OME has been studied in many randomized
controlled trials (Renvall et al. 1982, Tos et al.
1982, Williamson et al. 1994, Zielhuis et al.
1990). Rosenfeld and Kay (2003) recently
published a meta-analysis of studies concerning
the natural resolution of AOM and OME. After
untreated AOM, the resolution rate was 59%
after 1 month and 74% after 3 months. The
overall resolution rates for OME of unknown
duration were 20% after 3 months and 42%
after 6 months. When the duration of chronic
OME was unknown, the resolution rate was
26% after 6 months and 33% after 1 year.
2.2.6 Treatment
The tendency of OME towards spontaneous
resolution should be kept in mind when
treatment is planned. The duration and laterality
of MEE and the severity of the symptoms have
an influence on the choise of treatment and
should be documented at the time of the
diagnosis. The clinician should note the children
with a risk of speech, language and learning
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problems since they may need prompter
therapeutic intervention. With otherwise healthy
children with no risk factors for developmental
disturbances watchful waiting for 3 months
from the diagnosis of OME is recommended
by the American Academy of Pediatrics (2004).
Medications studied in the treatment of OME
have not shown to be effective. Antibiotic
treatment of OME has shown short-term
benefits, but antibiotics do not offer long-term
efficacy (Rosenfeld and Post 1992). Bluestone
and Klein (2001) recommend a treatment trial
with amoxicillin before surgical intervention for
patients who have not been treated with
antibiotics and have chronic MEE. When the
possible adverse effects and the increase in
bacterial resistance are considered, antibiotics
should be used in the treatment of OME only
in individually chosen cases. The efficacy of
both nasal topical and oral corticosteroids for
chronic OME has also been studied. Butler and
Van Der Voort (2002) conducted a meta-
analysis of the studies concerning oral or topical
nasal steroids for OME and found a short-term
benefit in the resolution of OME, but there was
no evidence of a long-term effect. Mandel et
al. (2002) came to the same conclusion in their
double-blind, randomized study with systemic
steroid with or without amoxicillin. They
compared the efficacy of 2 and 4 weeks courses
of oral prednisolone and amoxicillin together
with that of amoxicillin alone for the treatment
of chronic OME. After 2 weeks treatment 16.7%
and 33.3% of the children were free of MEE in
the amoxicillin group and amoxicillin-
prednisolone group, respectively. There were
no significant differences between the results
of 2 and 4 weeks treatment. Within 2 weeks of
finishing the treatment, there were no
significant differences between the groups. The
authors concluded that the medication they used
couldn’t be universally recommended for the
treatment of OME.
The operative treatment of OME has
traditionally been tympanostomy tube
placement with or without adenoidectomy.
Mandel et al. (1989, 1992) carried out two
separate trials in which they compared
myringotomy with tympanostomy tube
placement, myringotomy alone and no surgical
treatment in the treatment of chronic OME.
They showed that myringotomy with
tympanostomy tube insertion resulted in better
hearing and less time with effusion than
myringotomy alone or no surgery. Later, laser
myringotomy was studied in a prospective
randomized study in the treatment of OME, but
ventilation tube insertion showed to be more
effective (Koopman et al. 2004). The role of
adenoidectomy in the treatment of OME proved
effective in the study of Gates et al. (1987).
They randomized 578 children aged 4 to 8 years
with chronic OME into four groups. The first
received only myringotomy, the second was
treated with tympanostomy tube insertion, the
third underwent adenoidectomy and the fourth
was treated with both adenoidectomy and
tympanostomy tube insertion. The mean time
with MEE was shorter and the hearing was
better in the groups 2, 3 and 4 than in the group
1. Adenoidectomy with myringotomy and
adenoidectomy with tympanostomy tube
insertion resulted in lowered post-treatment
morbidity, and the results between these two
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groups were equal. Adenoidectomy is
recommended for the operative treatment of
OME in selected cases, such as when the size
of the adenoids leads to postnasal obstruction
or there is suspicion of chronic infection of the
adenoids or paranasal sinuses or when, after
tympanostomy tube extrusion, chronic MEE
recurs (Bluestone and Klein 2001, American
Academy of Pediatrics 2004).
2.3 Acute intratemporal and intracranial
           complications of otitis media
2.3.1 Acute intratemporal complications
The acute intratemporal complications of otitis
media include acute mastoiditis, petrositis,
labyrinthitis, facial paresis and external otitis
(Goldstein et al. 1998).
Acute mastoiditis (AM) is defined as an acute
suppurative infection of mastoid gas cell
system. It is staged, according to the spread of
infection, as follows: AM without periosteitis,
AM with periosteitis and acute mastoid osteitis
(Bluestone and Klein 2001). An AM without
periosteitis is usually an extension of middle
ear infection into mastoid. The infection is
limited to mastoid mucosa and no classical signs
(otalgia, retroauricular pain and swelling,
protrusion of the earlobe, fever) of AM are
found (Goldstein et al. 1998). In AM with
periosteitis the infection spreads to the
periosteum and mild signs of mastoid infection
are seen. In acute mastoid osteitis, also called
coalescent mastoiditis, there is osteitis in the
mastoid bone. Mastoid osteitis can spread and
lead to abscess formation. When the infection
is directed to the lateral wall of the mastoid
process, a subperiosteal abscess develops. If the
infection spreads to the inferior-medial tip of
the mastoid process, a Bezold abscess can
develop behind the insertion of
sternocleidomastoid muscle. Posterior spread
of the abscess leads to the “Citelli abscess”.
Both Bezold and Citelli abscesses are very rare
today (Bluestone and Klein 2001). Mastoiditis
is called subacute or latent, when the symptoms
and signs of middle ear infection do not resolve
within 10-14 days and the clinical signs of
mastoiditis are absent (Faye-Lund 1989,
Bluestone and Klein 2001). The diagnosis of
subacute mastoiditis is made by computed
tomography (CT). The spread of infection into
the petrosal gas cells is called petrositis. When
infection spreads to cochlea or vestibular
apparatus the complication is called
labyrinthitis. OM or its complications can cause
facial paralysis leading to loss of facial function.
REVIEW OF THE LITERATURE
32
Acute mastoiditis is the most commonly found
ITC of OM. The incidences of AM and the
number of performed mastoidectomies are
summarized in Table 3 for eight selected
studies. In the pre-antibiotic era the incidence
of AM was high (Lahikainen 1953). Palva and
Pulkkinen (1959) studied 12 781 cases of acute
and subacute OM during 1954-1959 and found
365 cases of acute or subacute mastoiditis in a
population of 400 000 (annual incidence 18.3/
100 000). Twenty years later, during 1974-1981,
the annual incidence of acute and latent
mastoiditis in Finland had decreased to 0.3/100
000 (Palva et al. 1985). The similar decrease in
the incidence of AM has been found also in
other developed countries. However, recent
reports from the United States and Israel show
increase in the incidence of AM (Bahadori et
al. 2000, Ghaffar et al. 2001, Katz et al. 2003).
The incidence of AM has been shown to be
associated with the use of antibiotics in the
treatment of AOM. Van Zuijlen et al. (2001)
compared the incidence of AM in several
European countries, Canada, Australia, and the
United States. In the Netherlands, where
antibiotics are used only in complicated cases
of AOM, the incidence of AM in children age
14 years and younger was higher (3.8/100 000)
than in countries with liberal antibiotic use (1.2-
2.0/100 000) in the treatment of AOM. On the
other hand, Antonelli et al. (1999) found
increased proportion of resistant bacteria in
AM. They suggested that antibiotic-resistant S.
pneumoniae might be responsible for the
increased rate of AM in their study. Therefore
the diagnostic accuracy of AOM should be
emphasized. A wide use of antibiotics has also
been connected to the appearance of subacute
or latent mastoiditis with a more chronic clinical
picture than that of classical AM (Faye-Lund
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Table 3. The incidence of acute mastoiditis and the performed mastoidectomy
Study
Number
of mastoiditis
cases
Annual
incidence of
mastoiditis
(N/100 000)
Palva and Pulkkinen 1959    1954-1959      0-69     400 000¹         365          18.3           58(16)
Juselius and Kaltiokallio 1972    1956-1971      0-79     160 000¹          43            1.8           43(100)
Harley et al. 1997                     1982-1993       0-15     NS                  58             NS           13(22)
Petersen et al. 1998    1977-1996      0-43     600 000¹         NS            NS           79(NS)
Goldstein et al. 1998    1980-1995      0-17     NS                  72             NS           18(25)
Vassbotn et al. 2002    1980-2000      0-41     500 000¹         61             0.6           50(88)
Butbul-Aviel et al. 2003    1990-2000      0-13     NS                  57             NS             5(9)
Katz et al. 2003    1990-2001      0-14     170 000²         116            6.1           32(28)
Number (%)
of
mastoidectomies
NS= not specified
¹= Whole population
²= Age<14 years
Age,
years
Study
period Population
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1989). The proportion of subperiosteal abscess
in children with AM has ranged from 31% to
66% (Petersen et al. 1998, Goldstein et al.
1998).
Otalgia, retroauricular pain and swelling,
protrusion of the earlobe and fever are the most
frequent clinical signs of AM, especially found
in children under 3 years of age (Goldstein et
al. 1998, Vassbotn et al. 2002, Katz et al. 2003).
A high fever should be considered as a possible
sign of complicated AOM with bacteremia
(Schutzman et al. 1991). COM and
cholesteatoma behind AM are found more
frequently in adults than in pediatric patients
(Palva and Pulkkinen 1959, Juselius and
Kaltiokallio 1972). Most patients have had
antibiotic treatment for AOM before the
diagnosis of AM, and they usually have had a
longer duration of symptoms, too (Luntz et al.
2001). S. pneumoniae (25-33%), H. influenzae
(6-14%), S. pyogenes (2-26%) and
Pseudomonas aeruginosa (6-29%) are the
bacteria most frequently found in MEE samples
of AM (Harley et al. 1997, Goldstein et al. 1998,
Khafif et al. 1998, Katz et al. 2003). M.
catarrhalis, as a single pathogen, has not been
reported to be associated with AM, but
Marcinak and Maloney (1987) found M.
catarrhalis in association with S. pneumoniae
in ME from a 5-month-old child with recurrent
mastoiditis. The use of mastoidectomy in the
treatment of AM has varied, but currently the
treatment is preferentially conservative. In
antimicrobial treatment, 2nd and 3rd generation
cephalosporins are preferred (Goldstein et al.
1998, Vassbotn et al. 2002, Katz et al. 2003).
Mastoidectomy is usually recommended if
coalescent or abscess forming mastoiditis,
intracranial complications of AM or
cholesteatoma is suspected (Goldstein et al
1998, Taylor and Berkowitz 2004).
Facial paralysis is a frequent complication of
AM. Ellefsen and Bonding (1996) reported the
annual incidence of facial paralysis to be 5/100
000 in association with AOM. Goldstein et al.
(1998) studied 100 children with ITC of OM
and found 22 children with a facial paralysis.
Fifty percent of the children were 3 years or
younger, and 77% were 6 years or younger. The
bacteria most frequently cultured from the MEE
were S. pneumoniae (9.5%) and P. aeruginosa
(9.5%). Mastoidectomy was performed in 4
(18.2%) children, and 1 patient had facial-nerve
decompression. All the children except one
achieved a recovery of House grade I (79%) or
grade II (16%). For one child the final House
grade was V. Mastoidectomy is recommended
in facial paralysis if coalescent mastoiditis,
chronic suppurative OM or cholesteatoma is
involved. Facial decompression is indicated
only in cases of total facial paralysis and
suspicion of nerve compression (Bluestone and
Klein 2001).
Acute petrositis and labyrinthitis are rare
complications of AM. Acute petrositis is often
associated with an ICC of OM (Goldstein et al.
1998). The signs of petrositis include deep ear
pain, discharge from the middle ear, pain behind
the eye and paralysis of the abducens nerve.
However, the classic Gradenigo´s triad is rarely
seen. S. pneumoniae, H. influenzae and P.
aeruginosa are the bacteria found in acute
petrositis. The treatment for acute petrositis
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includes the administration of a intravenous
broad-spectrum antibiotic and mastoidectomy
(Bluestone and Klein 2001). Labyrinthitis can
be classified into serous or toxic, suppurative
and meningogenic suppurative labyrinthitis.
Serous labyrinthitis is the most common form.
However, these infections are so rare that
numerical values of the incidence of
labyrinthitis in association with AOM or AM
in developed countries have not been published
recently. The clinical signs of labyrinthitis
include sudden mixed hearing loss and vertigo
with AOM or its complications. In suppurative
labyrinthitis the signs and symptoms are often
more profound, and they are often associated
with deep ear pain, nausea and vomiting.
Goldstein et al. (1998) found 4 patients with
labyrinthitis (2 serous and 2 suppurative). They
all received broad-spectrum antibiotics
intravenously, and in one patient an intact canal-
wall mastoidectomy was performed. The
patients with serous labyrinthitis recovered
fully, but those with suppurative labyrinthitis
suffered from profound sensorineural hearing
loss in the affected ear.
In conclusion, although acute ITCs of OM are
rare today, they still cause morbidity and need
prompt treatment. Occasionally permanent
damage of the ear leads to hearing loss, vertigo,
and sometimes, facial weakness. In children
these complications are usually associated with
AOM, but in adults COM and cholesteatoma
are also significant predisposing factors.
2.3.2 Acute intracranial complications
The acute intracranial complications of OM
include meningitis, focal encephalitis,
extradural abscess, subdural empyema, brain
abscess, sinus thrombosis and otitic
hydrocephalus (Bluestone and Klein 2001). In
meningitis, the infection has spread to the
meninges. The spread of infection can happen
either by direct invasion or by hematogenous
route. Encephalitis means the spread of
infection into brain. An extradural abscess is a
collection of purulent material outside, but
adjacent to the dura mater. A subdural empyema
is a collection of purulent material between the
dura mater and the arachnoid membrane. A
brain abscess is a collection of purulent material
inside the brain. A sinus thrombosis developes
usually to the lateral or sigmoid sinus. A mastoid
infection produces thrombophlebitis and
thrombus formation into the adjacent sinus.
Otitic hydrocephalus means increased
intracranial pressure without dilatation of the
ventricles and abnormalities of the
cerebrospinal fluid as a complication of OM. It
is usually associated with a lateral sinus
thrombosis (Tomkinson et al. 1997).
Acute ICC of OM are encountered today only
rarely. In the preantibiotic era, a marked
proportion (2.3%) of OM was complicated by
ICC (Bluestone and Klein 2001) and led to
death in most cases (Kafka 1935). According
to the study by Tarkkanen and Kohonen (1970),
99 (3.3/year) and 3 (0.4/year) otogenic
brainabscesses were treated in 1930-60 and
1961-1969, respectively in the
Otolaryngological Hospital of University of
Helsinki. This dramatic decrease in the
incidence was considered to be due to the
antibiotic treatment of OM and development
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of the health care system. A summary of the
incidences of different otogenic ICCs is shown
in Table 4. Meningitis is found in 13-43% of
patients with ICC of OM (Goldstein et al. 1998,
Albers 1999, Sennaroglu and Sozeri 2000).
Sinus thrombosis and intracranial abscesses are
encountered in 0-38% and 0-44% of patients,
respectively (Goldstein et al. 1998, Albers 1999,
Sennaroglu and Sozeri 2000). Otitic
hydrocephalus and encephalitis have been
reported in 0-44% and 0-6% of patients,
respectively (Goldstein et al. 1998, Albers 1999,
Sennaroglu and Sozeri 2000). Mortality from
ICCs in conjunction with OM is low in
developed countries, but in countries with
developing health care systems mortality is still
high (23-29%) (Kangsanarak et al. 1995,
Sennaroglu and Sozeri 2000).
ICCs arise from the direct invasion of the
infection from the middle ear and mastoid or
through the hematogenous spread to the
intracranial space (Bluestone and Klein 2001).
Infection can invade the intracranial space
through the progressive thrombophlebitis, by
eroding the bony wall of the skull base, or by
extending through the pathways like previous
skull fractures or perilymphatic fistula
(Bluestone and Klein 2001). Meningitis rarely
develops through direct invasion (Eavey et al.
1985, Bluestone and Klein 2001). Extradural
intracranial abscesses usually develop through
the direct invasion when cholesteatoma or
osteitis erodes the bony skull base. Subdural
empyema generally occurs as a direct invasion,
but sometimes through thrombophlebitis. A
brain abscess can develop through the
hematogenous spreading, but often the
underlying cause of infection is cholesteatoma
or COM and the infection invades through bony
erosion in the tegmen tympani (Sennaroglu and
Sozeri 2000). The sigmoid sinus is adjacent to
the mastoid, and thrombophlebitis develops
through the direct extension to the sinus
(Bluestone and Klein 2001). The clinical picture
in ICC is often more severe than in other
complications of OM. The most common
symptoms are headache, fever and drainage of
the ear in 49-58%, 25-75%, 8-92% of patients,
respectively (Schwaber et al. 1989,
Kangsanarak et al.1995, Yen et al. 1995).
Earache, nausea, fever and impairment of
consciousness are also frequently seen
symptoms of ICC. In meningitis, stiffness of
the neck is often found. The patients with
meningitis, subdural empyema and sinus
thrombophlebitis often have signs of septic
infection with high fever, seizures, somnolence,
neurological deficiencies and severe headache
(Yen et al. 1995, Bradley et al. 2002). However,
sometimes the symptoms of ICC can be subtle
and develop slowly, especially if the underlying
OM is treated with antibiotics (Martin-Hirsch
et al. 1991). Otitic hydrocephalus is usually
accompanied by sinus thrombosis. The
pathogenesis of this condition is unknown. It is
characterized by increased intracranial pressure
without dilated ventricles. The signs and
symptoms of otitic hydrocephalus include
headache, nausea, vomiting, disturbances in
vision, diplopia, abducens paresis, and
papiledema (Mathisen and Johnson 1997,
Bluestone and Klein 2001).
The bacteriology of otogenic meningitis
resembles that of OM with S. pneumoniae being
REVIEW OF THE LITERATURE
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the most commonly grown bacterium in the
cultures of cerebrospinal fluid (Juselius and
Kaltiokallio 1972, Bluestone and Klein 2001).
The bacteriology in intracranial abscesses is far
more variable. Both virulent invasive bacteria
such as many gram-positive cocci are found,
as well as bacteria with low virulence such as
many gram-negative bacilli and anaerobic
bacteria (Bluestone and Klein 2001).
Streptococcus species are found in up to 56%
and staphylococcus in 13% of the cultures of
intracranial abscess aspirates. Anaerobes are
found in 16%, and Enterobacteriaceae appears
in 9%. The bacterial etiology of a brain abscess
is often polymicrobial (Tattevin et al. 2003).
Barry et al. (1999) made a retrospective review
of 79 adult patients with otogenic intracranial
infection. S. pneumoniae was the leading
pathogen in 48% of cases. It was found
especially in complications with AOM. Proteus
mirabilis (5%) and anaerobes (7%) were found
with cholesteatomatous otitis. S.aureus (1%)
and P. aeruginosa (1%) were found with COM
and cholesteatoma.
The diagnosis of an ICC is based on the clinical
picture combined with the results of radiological
imaging. Computed tomography (CT) of the
brain is usually recommended as the primary
radiological examination for evaluating
otogenic ICC. CT gives more precise
information of the bony structures of the
mastoid and middle ear and of the invasion of
the infection. Magnetic resonance imaging
(MRI) can be used to further evaluate ICC
because of its higher sensitivity to detect extra-
axial fluid collections and possible vascular
problems (Vazquez et al. 2003). The treatment
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of ICC is based on the intravenous
administration of broad-spectrum antibiotics
(e.g. ampicillin and metronidazole with 3rd
generation cephalosporines) and surgery
(Mathisen and Johnson 1997, Infection in
Neurosurgery Working Party of the British
Society for Antimicrobial Chemotherapy 2000).
Mastoidectomy is used to drain the source of
infection. Neurosurgical approaches are used
to drain the intracranial abscesses. The
treatment of brain abscesses usually includes
long-term antibiotic treatment and needle
aspiration of the abscess (Mathisen and Johnson
1997). Open craniotomy is used rarely. Early
operative treatment is crucial, and therefore the
need for early and accurate diagnosis should
be emphasized. In the treatment of otogenic
sinus thrombosis, intravenously administered
antibiotics and mastoidectomy are the
cornerstones. A recent report (Agarwal et al.
2003) showed that sigmoid sinus thrombosis
has a natural capability to recanalize, and, on
the other hand, there is no clear evidence of the
benefits of anticoagulation (Bradley et al. 2003).
Therefore, anticoagulation should not be used
as a standard treatment of sigmoid sinus
thrombosis (Bradley et al. 2002, Agarwal et al.
2003).
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3. AIMS OF THE STUDY
AIMS OF THE STUDY
This study had the following two main aims: first, to evaluate the bacteriology of AOM and OME
with a special interest focused on A. otitidis and its association with these diseases and second, to
assess the current incidence and clinical picture of acute complications of OM in southern Finland.
The following special issues were examined:
1. Is A. otitidis found in AOM, and is it associated with the clinical outcome of patients
with AOM?
2. Is A. otitidis associated with the development of OME?
3. Has the clinical picture and outcome of OM patients with ITC and ICC changed during
the last 10 years?
4. Which clinical parameters are associated with a poor outcome in ITC and ICC of OM,
and can these parameters be used as predictive factors when treatment is planned?
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4.1.1 Acute otitis media (I)
Altogether 118 children with 118 episodes of
AOM were included in this study. The children
were examined either at the Department of
Otorhinolaryngology in the Helsinki University
Central Hospital (HUCH) or at a private
otolaryngological center, in 1990-1992. The
guidelines of the Finnish Consensus Conference
were followed in the diagnosis and treatment
of AOM (Karma et al. 1987). The diagnostic
criteria of AOM included both acute ear-related
symptoms (at least one of the following:
earache, tugging or rubbing of the ear,
irritability, restless sleep, fever, loss of appetite,
other simultaneous respiratory tract infection)
and signs of MEE. The presence of MEE was
verified both by pneumatic otoscopy and
4. MATERIAL AND METHODS
Study  Diagnosis    Age Number of patients
I      AOM 0-7 years 118
II      OME 0-12 years 123
III and V  ITC or ICC 0-15 years 33
IV  ITC or ICC >15 years 30
tympanometry. Children with written informed
consent from their parents were included in the
study. Children with OME, tympanostomy
tubes, spontaneous perforation of the tympanic
membrane, or antibiotic treatment within the
preceding week were excluded.
4.1.2 Otitis media with effusion (II)
The study population consisted of 123 children
with OME, who were referred to the
Department of Otolaryngology in HUCH for
tympanostomy tube insertion in 1993-1994. The
age of the children ranged from 7 months to 12
years (median 2 years 5 months). The inclusion
criteria were MEE behind an intact tympanic
MATERIAL AND METHODS
4.1. Patients
The conclusion of the patients included in this
study (I, II, III, IV, V) is in Table 5.
Table 5. The patients included in the study
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membrane for at least 1 month with neither
signs nor symptoms of AOM or URI. The onset
and duration of MEE was determined from the
clinical follow-up data. The presence of MEE
was verified both by pneumatic otoscopy and
tympanometry. Children with purulent MEE
were excluded.
4.1.3 Complications of otitis media
(III, IV, V)
All the adult (older than 15 years) and pediatric
(15 years and younger) patients treated for acute
ITC or ICC of OM during 1990-2000 at the
Department of Otorhinolaryngology in HUCH
were included. The hospital discharge codes
[according to the International Classification of
Diseases (ICD-9 and ICD-10)] have been saved
in a computer database since April 1990, and
this database was used to identify the patients
for this study. The inclusion diagnoses of
otogenic ITCs included acute and latent
mastoiditis, labyrinthitis, acute petrositis and
facial paralysis. The diagnostic criteria for AM
were a clinical picture of AM presenting with
at least one of the following symptoms or signs:
postauricular tenderness, erythema, swelling,
fluctuation of the mastoid area or protrusion of
the auricule in combination with radiological
evidence of mastoid infection (effusion in the
mastoid with signs of septal destruction)
(Rosenfeld and Bluestone 1999) in an OM
patient. The otogenic ICC included meningitis,
extradural abscess, brain abscess, subdural
abscess, intracranial sinus thrombosis and
hydrocephalus. In study III the patients with
earlier known COM or cholesteatoma were
excluded.
4.2 Samples
4.2.1 Acute otitis media (I)
MEE samples were obtained during the initial
visit. The ear canal was first mechanically
cleaned and the TM anesthetized with 90%
liquefied phenol. Myringotomy was performed
through the anteroinferior part of the TM. MEE
was aspirated into a glass suction tip. A cotton-
tipped swab was dipped directly into the
aspirate. The swabs were immediately placed
in modified Stuart transport media
(Transpocult, Orion Diagnostica, Espoo,
Finland) and transported at +4°C to the
bacteriological laboratory. Thereafter, the
sample was rinsed into a polypropylene
microtube with 0.5 ml of phosphate buffered
saline (PBS). Initially only a bacterial culture
was done. Then the rest of the samples were
stored at -70ºC for a later PCR analysis.
4.2.2 Otitis media with effusion (II)
All the patients with OME were under general
anesthesia during the tympanostomy tube
insertion when the MEE samples were obtained.
The operation was carried out under the control
of an operating microscope without the ear
canal being sterilized. In bilateral cases, only
the MEE of the right ear was collected. The ear
canal was first cleaned and myringotomy was
performed in the anteroinferior part of the
tympanic membrane. A MEE sample was
aspirated with an electric suction device into a
Tym-Tap collector (Juhn Tym-Tap, Xomed
Inc., Jacksonville, Florida, USA). The samples
were cultured and stored in the same manner
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as the samples in study I. MEE was classified
as mucoid, mucoserous or serous according to
its physical appearance. Clear, glue-like MEE
was classified as mucoid. Viscous, but liquid
MEE, was considered mucoserous. Clear,
running MEE was rated as serous.
4.3  Methods
4.3.1  Clinical evaluation
4.3.1.1  Acute otitis media (I)
The patients’ medical history and the signs and
symptoms were recorded. The clinical infection
status was assessed at the primary visit as mild
or strong. The clinical criteria used were the
overall clinical condition (good, intermediate,
poor), the strength of the ear-related symptoms
(e.g. earache, irritability), bilaterality, and the
severity of the inflammatory signs of the
tympanic membrane (color, position, mobility,
disappearance of normal tympanic membrane
landmarks). The same ear-, nose- and throat
specialist did the clinical assessment in all
children. All of the children were treated with
amoxicillin clavulanate for 7 days (40 mg of
amoxicillin/kg for 24 h, divided into 2 doses).
The clinical outcome was evaluated in control
visits 2 weeks and 6 weeks later, and at 4-week
intervals if clinically necessary. The last control
for all the children took place after 6 months.
The children whose signs and symptoms of
AOM had resolved or had improved by the time
of the 2-week control visit were considered
cured or improved, respectively. Those whose
signs and symptoms had not improved or had
worsened during the 2 weeks preceding the
control visit were diagnosed as clinical failures.
The children whose signs and symptoms first
improved but again worsened or recurred
between the 2- and 6-week controls were
classified as early recurrences. The persistence
of MEE over a month after the treatment and
the development of asymptomatic MEE of at
least 8 weeks´ duration during the 6 months of
follow-up were also registered.
4.3.1.2   Otitis media with effusion (II)
The medical history, signs and symptoms of
OME were recorded. The diagnostic criteria for
OME were MEE of at least one month behind
an intact TM and no signs or symptoms of
neither AOM nor URI. The presence of MEE
was verified both by pneumatic otoscopy and
tympanometry (HandTymp 2002, Rexton
Danplex A/S, Copenhagen, Denmark). A flat
tympanogram with low compliance was
considered to indicate MEE. The duration of
OME was assessed in each case from the
clinical follow-up data. The follow-up was
carried out at the Department of
Otorhinolaryngology in HUCH. The history of
earlier attacks of respiratory infections and
AOM within the preceding 6 months was also
recorded.
4.3.1.3   Complications of otitis media (III,
               IV, V)
The patients history of known risk factors for
AOM, demographics, previous development
and treatment of OM before the admittance to
the hospital and possible residual symptoms and
consequences after treatment were evaluated
MATERIAL AND METHODS
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with the use of a structural questionnaire
(appendix) sent to each patient. The patients´
clinical data were recorded structurally in a
retrospective chart review. The incidence was
defined as the number of patients in the age
group with a discharge diagnosis of ICC or ITC
divided by the number of the population in the
same age range in the hospital district (288 000
children, 1 040 000 adults) and the duration of
the study period (10 years).
4.3.2     Bacterial culture (I, II)
Cultures were done within 12 hours onto blood
agar and chocolate plates and selective blood
agar plates with 5 µg/ml of gentamycin. The
plates were incubated at +37°C in 5% carbon
dioxide for 1 to 3 days. The bacterial
identification was done using standard methods
(Balows et al. 1991, Virolainen et al. 1994).
4.3.3    Multiplex polymerase chain
              reaction (I, II)
Multiplex PCR was used for the detection of
four middle ear pathogens, including an internal
amplification control (Hendolin et al. 2000).
DNA purification was based on the QIAamp
(Qiagen, Hilden, Germany) kit. The reaction
contained specific forward primers for A.
otitidis, H. influenzae, M. catarrhalis and S.
pneumoniae, and a universal reverse primer that
was labeled with the fluorescent dye Cy5. All
of the reactions were prepared from pre-aliquot
reagents in a laminar flow hood using aerosol-
resistant micropipette tips. Each PCR analysis
of 20 to 30 samples included one positive
control and two or more blanks with reagents
only. After the PCR, the amplification products
were detected on an automated Alf Express
DNA-sequencer (Pharmacia Biotech, Uppsala,
Sweden) (Hendolin et al. 1999). The optimal
sample volume in the PCR was investigated
with different volumes of eight specimens.
From a completed reaction, 5 µl was loaded on
the ALF Express sequencing machine. Most of
the positive results were obtained with a 20-µl
sample, and therefore this volume was chosen
for the analysis of the entire set of MEE
specimens.
4.4 Statistical methods
In studies I and II, statistical analyses were
carried out using the chi-square test with Yates´
correction and the two-tailed Fisher’s exact test
when appropriate at a significance level of
P<0.05. McNemar´s test was used when the
bacterial detection methods were compared.
In studies III and IV the statistical analysis was
carried out with the chi-square test and Fisher´s
exact test using a significance level of P<0.05
to determine the risk factors and clinical
features associated with the performed
mastoidectomy, hospitalization for longer than
7 days and permanent complications after
treatment.
4.5 Ethics
The study protocol was approved by the Ethics
Committee of the Department of
Otorhinolaryngology, Helsinki University
Central Hospital, Helsinki, Finland.
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5.1       Methodological aspects
The sample collection in the AOM and OME
studies were carried out in 1990-1992 and 1993-
1994, respectively. The bacterial culture was
done immediately after the sample collection,
and the bacterial analysis was carried out using
generally accepted methods. Thereafter the
MEE samples were stored frozen at -70ºC. The
development of multiplex PCR technique
(Hendolin et al. 1997) offered a new method to
study the MEE samples. The sensitivity of the
multiplex PCR for the four bacteria in the OME
study was good. In the AOM study the
sensitivity for S.pneumoniae and especially for
H. influenzae was markedly lower. In AOM, the
proportions of multiplex PCR positive findings
were similar to those of the bacterial culture.
However, for each bacterial species, there were
MEE samples that were positive only by either
of the test methods, and negative for the other.
Multiplex PCR was the least sensitive for H.
influenzae (I, Table 3). The DNA purification
method may have influenced to the recovery
rate of bacterial DNA (Hendolin et al. 2000).
The recovery rate of H. influenzae DNA has
been markedly lower with QIAamp DNA
purification than with phenol-extraction
(Hotomi et al. 1993, Post et al. 1995, Hendolin
et al. 2000). However, the possible effects of
the long storage time on MEE samples are not
known. The specificity of the multiplex PCR
for the four pathogens had been determined in
an earlier study by Hendolin et al. (1997). The
specificity was later confirmed with various
bacterial species found in the nasopharynx.
5. RESULTS AND DISCUSSION
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Three of the six viridans group streptococci that
were tested, Streptococcus oralis,
Streptococcus mitis, Streptococcus sanguis, and
two of the three milleri group streptococci,
Streptococcus constellatus and Streptococcus
intermedius, yielded an amplification product
that was similar to that of S. pneumoniae.
However, no amplification product was
obtained from streptococci that are reported to
cause infections of the pharynx and lower
respiratory tract (i.e., Streptococcus agalactiae
(Lancefield group B), Streptococcus group C,
Streptococcus group G). Although the
amplification of certain species might lead to
false positive results, they have very seldom, if
ever, been encountered in AOM or OME
(Bluestone et al. 1992, Virolainen et al. 1994,
Kilpi et al. 2001). Moreover, the samples in this
study were obtained through a myringotomized
tympanic membrane, and this procedure
minimizes the risk of cross-contamination with
the aforementioned reacting species from the
nasopharynx.
The studies concerning ITCs and ICCs of OM
were carried out using a retrospective chart
review and a patient questionnaire. All the
clinical records were available and the
questionnaire was sent to all of the patients. The
patients´ responses to the questionnaire were
confirmed with a call when needed. For the
children, the response to the questionnaire was
89% (29/33). In the adult group, 20 patients
(67%) responded, 3 (10%) patients had died,
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and 7 (23%) either refused to answer or could
not be found. The author collected the data
structurally. All the patients who did not respond
to the questionnaire had ITC of OM. There were
no other significant differences in the risk
factors for AOM, clinical picture, treatment or
outcome between those who responded and
those who did not respond to the questionnaire.
5.2       Alloiococcus otitidis in acute
             otitis media (I)
A. otitidis was not found by culture in this study
of AOM. Sixty (51%) of the 118 MEE
specimens showed growth of any bacteria by
culture, and S. pneumoniae was the most
common finding. The number of culture
positive MEE samples was low when compared
with 67-84% in other studies (Luotonen et al.
1981, Bluestone et al. 1992). PCR was used to
assess the presence of A. otitidis in the
specimens. There is still some question about
the clinical significance of positive PCR results
for OM because PCR detects DNA from both
viable and non-viable bacteria (Post et al. 1995,
Palmu et al. 2004). However, according to the
chinchilla model of OM, bacterial DNA from
non-viable bacteria does not persist longer than
a day in an amplifiable form in the presence of
an effusion in the middle ear (Aul et al. 1998).
Palmu et al. (2004) showed, that a positive
pneumococcal PCR seems to indicate the
presence of viable, but often nonculturable, S.
pneumoniae in MEE of AOM. Thus a positive
PCR for MEE should be considered as evidence
of either bacterial colonization or even ongoing
bacterial infection in the middle ear.
A. otitidis was detected in 25% (30 of 118) of
the MEE samples of AOM with PCR. It was
more often positive in the MEE samples of the
older children (>2 years) than in those of the
younger children (<2 years), 37% (22 of 59)
and 14% (8 of 59), respectively (P<0.01) (I,
Table 2). There are no other reports of A. otitidis
in AOM to compare with our results. However,
A. otitidis has been found in 4,8% of the nasal
and ear canal specimens (50 nasal, 95 ear canal)
from 50 healthy children by PCR (Durmaz et
al. 2002). In this study, no difference was found
in the clinical response between the children
with A. otitidis positive or negative PCR (I,
Figure 1). The positive A. otitidis PCR finding
was not statistically significantly associated
with the severity of the infection, the duration
of pre-treatment earache, the laterality of the
disease or otitis proneness (3 episodes of AOM
within 6 months). Nor did the history of
respiratory or skin allergy or earlier
adenoidectomy differ between the A. otitidis
positive and the A. otitidis negative children.
5.3    Alloiococcus otitidis in otitis media
           with effusion (II)
Bacteria were cultured in 55 (45%) of the 123
MEE samples of OME. In their recent study,
Brook et al. (2003) reported similar finding. In
this study, the major OM pathogens (S.
pneumoniae, H. influenzae, M. catarrhalis)
were found in 33% (40/123) of the MEE
samples, which is concordant with the results
of Bluestone et al. (1992).  A. otitidis was not
detected by culture in this study. However, it
has been cultured in 5% of MEE of OME in
earlier studies (Faden and Dryja 1989, Bosley
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et al. 1995).
Altogether 110 (89%) of the 123 MEE samples
were positive in either PCR or culture for one
or more of the four studied bacteria. The
proportion of PCR-positive specimens was
high, but within the same range as in previous
reports (Post et al. 1995, Beswick et al. 1999,
Hendolin et al. 1999). Twenty-five (20%) of the
samples were positive for A. otitidis in the PCR.
In earlier studies, A. otitidis has been found by
PCR in 20% to 50% of the MEE samples from
children with OME (Hendolin et al. 1997,
Hendolin et al. 1999, Kalcioglu et al. 2002). In
this study, the detection rate for S. pneumoniae
(35%) by PCR was a little higher than in earlier
studies (Post et al. 1995, Hendolin et al. 1999,
Gok et al. 2002). H. influenzae was detected in
33% of the MEE samples, which is in the same
range as in the study of Gok et al. (2002), but
lower than the 52-54.6% found in earlier studies
(Post et al. 1995, Hendolin et al. 1997). The
number of MEE samples positive for M.
catarrhalis was higher than reported in other
studies (Post et al. 1995, Hendolin et al. 1999,
Gok et al. 2001).
A. otitidis was detected more often in the
multiple positive specimens than in the single
positive specimens (P<0.05). The relative
frequency of M. catarrhalis was greater for the
single positive specimens than for the multiple
positive specimens (P<0.05). The distributions
of S. pneumoniae or H. influenzae between the
single and multiple positive MEE samples
showed no statistically significant difference (II,
Table 1). PCR was significantly more sensitive
than culture (P<0.01). All but two (5%) of the
culture-positive (H. influenzae) specimens
tested specifically positive in the PCR. A.
otitidis DNA was detected in 3 (17%) of 18 H.
influenzae culture-positive MEE samples,  3
(21%) of 14 S. pneumoniae culture-positive
MEE samples, but none of the 8 MEE samples
that tested positive for M. catarrhalis by culture.
Of the 68 MEE samples negative for any
bacteria in culture, 13 (19%) were PCR-positive
for A. otitidis.
Children aged 2 years or older seemed to have
more positive results for A. otitidis in the PCR
than the younger children did, 19 (24%) of 78
children and 6 (13%) of 45 children,
respectively. Hendolin et al. (1999) studied 67
MEE samples from children with OME by
multiplex PCR. In their study, 33% of the
children younger than 2 years were A.otitidis
positive compared with 49% of the children 2
years or older. In this study, S. pneumoniae
occurred in 21 (47%) MEE samples from
children younger than 2 years and in 22 (28%)
MEE samples from children aged 2 years or
older (P<0.05). The PCR prevalence of H.
influenzae and M. catarrhalis did not vary in
the different age groups. The persistence of
MEE differed from 1 to 12 (median 3.5)
months, and in 70% of the cases MEE persisted
for 3 months or longer. A. otitidis was PCR
positive in 3 samples (8%) of the MEE that had
persisted less than 3 months and in 22 samples
(26%) that had persisted 3 months or longer
(P<0.05). This differs from the results of
Hendolin et al. (1999). Their material showed
no differences in the proportion of A. otitidis in
MEEs of different durations. In this study, no
statistically significant differences were found
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for the findings of the other tested bacterial
species in association with the persistence of
MEE. Major pathogens were cultured more
often in children with recurrent (4) attacks of
AOM than in those whose attacks were only
occasional (0-3) (49% and 24%, respectively)
(p<0.01). However, the number of earlier AOM
attacks did not statistically significantly
correlate with the number of positive effusions
in the PCR (II, Table 4). The type of MEE was
mucoid, mucoserous or serous in 63 (51%), 56
(46%) and 4 (3%) samples, respectively.
Pathogens were cultured in 24 (44%) of the
mucoid MEE samples and in 30 (55%) of the
mucoserous MEE samples. No pathogens were
found in the serous MEE samples by culture
only. The proportion of A. otitidis was higher
in the mucous MEE samples than in the
mucoserous MEE samples (P<0.05). The
proportion of M. catarrhalis in the PCR was
significantly lower in the mucous MEE samples
than in the mucoserous and serous samples
(P<0.05).  For the other bacterial species, no
similar associations were observed (II, Table
2). In the study of Hendolin et al. (1999) the
proportions of A. otitidis and the three major
middle-ear pathogens in different type of
effusions were equal (1999).
5.4 Acute complications of otitis
          media in children (III, V)
During the 10-year study period, 33 children
[70% (23/33) males and 30% (10/33) females]
aged from 3 months to 14.2 years (mean 4.5
years) were treated. The annual age adjusted
incidence of all complications was 1.1/100 000.
It has slightly decreased over the last three
decades (Palva et al. 1985). It is also less than
in previous reports from other European
countries (Petersen et al. 1998,Vassbotn et al.
2002). In the Netherlands, where the policy is
different and the antibiotic prescription rate for
AOM is nowadays low, the incidence of acute
mastoiditis (3.8/100 000) is markedly higher
than that of this study (Van Zuijlen et al. 2001).
Forty-two percent (14/33) of the complications
occurred in 1990-1994 and 58% (19/33) took
place in 1996-2000 (III, Figure 2). The monthly
frequency of complications was greatest in
autumn (P<0.05). Five children (15%) had
chronic disease or genetic or developmental
disturbances, and 13 (39%) had recurrent URI
combined with AOM. The duration of ear
symptoms before admission to the hospital
ranged from 1 to 45 days (mean 8.03 days), and
70% (23/33) of the patients were admitted to
the hospital within 1 week of the occurrence of
ear symptoms. All of the children were admitted
to the hospital within 2 days after the first signs
of complications. The duration of ear symptoms
was not statistically significantly associated
with the performed mastoidectomy or with the
duration of hospitalization.
The most often found signs of complication in
children were retroauricular tenderness 28
(85%), erythema 26 (79%) and swelling 24
(73%, III, Table 1) as in many previous studies
(Tarantino et al. 2002, Butbul-Aviel et al. 2003).
ITC was found in 97% (32/33) and ICC in 3%
(1/33) of the patients. The only ICC was an
extradural abscess with meningitis. Most of the
children (19/33) had strong local or general
signs of infection. In addition 6% (2/33) had
signs of septic infection with a high fever and
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changes in their hemodynamics and level of
consciousness. The severity of the signs and
symptoms of infection at the time of admittance
was not statistically significantly associated
with the performed mastoidectomy or
hospitalization for over 7 days; similar findings
have also been reported in earlier studies
(Goldstein et al. 1998, Khafif et al. 1998).
Eighteen patients (55%) were on antibiotic
medication because of AOM prior to the
diagnosis of the complication. Antibiotic
treatment or the lack of it before the diagnosis
of the complication was not statistically
significantly associated with the length of
hospitalization or the performed
mastoidectomy. Goldstein et al. (1998) studied
100 children with ITC. They found no
significant association of antecedent otologic
history, presenting symptoms and prior
antibiotic use with the need for mastoidectomy
or with hospitalization over 7 days. In this study,
the signs of subperiosteal abscess, facial paresis
or ICC were associated with the performed
mastoidectomy (P<0.05) and this is concordant
with the results of Goldstein et al. (1998).
In the laboratory examinations neither a high
level of C-reactive protein (CRP) (>100mg/ml)
nor an elevated white blood cell count (>15 000/
mm³) was statistically significantly associated
with the performed mastoidectomy or
hospitalization for over 7 days. This agrees with
the earlier report by Goldstein et al (1998).
S. pneumoniae, in 25% (8/32) of the MEE or
ME samples, was the most frequently found
bacteria as in most studies concerning acute
complications of AOM (Petersen et al. 1998,
Tarantino et al. 2002, Vassbotn et al. 2002). P.
aeruginosa was cultured in 22% (7/32) of the
MEE or ME samples (III, Table 2). The same
high incidence of P. aeruginosa has been
reported also in two reports from Israel (Khafif
et al. 1998, Butbul-Aviel et al. 2003). Three of
the four children with tympanostomy tubes at
the time of the complication showed P.
aeruginosa in the culture. M. catarrhalis grew
in the MEE of one child with AM. There are no
earlier reports of AM caused solely by M.
catarrhalis, although one report has shown that
M. catarrhalis and S. pneumoniae together have
caused AM (Marcinak and Maloney 1987).
Mastoidectomy was performed on both S.
pyogenes positive patients. No correlation
between the performed mastoidectomy and the
bacterial species cultured in the MEE was seen
among the other patients. All the children
underwent a radiographic evaluation.
Twentynine (88%) had plain mastoid
radiographs, and four (12%) had CT scans. The
radioglogical examinations suggested
mastoiditis in all children.
The duration of hospitalization ranged from 1
to 23 days (mean 6.6 days). The initial antibiotic
treatment in the hospital was intravenous
cephuroxime in 94% (31/33) of the children.
One child was treated with intravenous
penicillin-G and one with intravenous
clarithromycin. Bluestone and Klein (2001)
recommend cephuroxime sodium as an
empirical parenteral antimicrobial therapy until
results of culture and susceptibility studies are
available. Myringotomy without tympanostomy
was performed in 27% (9 of 33) of the children.
Tympanostomy tubes were inserted in 58% (19
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of 33). In four cases, tympanostomy was the
only operative treatment. The remaining 15
tympanostomies were combined with
mastoidectomy. Mastoidectomy was performed
in 55% (18 of 33) of the children, 12 (67%) of
them in 1990-1994 and 6 (33%) in 1995-2000
(P<0.05) (III, Figure 2). The proportion of
operative treatment was high and similar results
have been published in Norway and Denmark
(Vassbotn et al. 2001, Petersen et al. 1998).
However, the proportion of operative treatment
has been markedly lower (9-35%) in many
recent studies (Goldstein et al. 1998, Tarantino
et al. 2002, Butbul-Aviel et al. 2003). In this
study, mastoidectomy was performed on all the
children with subperiosteal abscess, facial
paresis or ICC. Facial decompression was not
done for any of the patients with facial paresis.
During the follow-up, at least 45% (15 of 33)
of the patients underwent an audiometric
evaluation. The audiometric follow-up was done
in the study hospital only in the children who
had lowered hearing immediately following the
treatment of the complication. No child under
4 years of age underwent an audiometric
evaluation. The questionnaire did not reveal any
hearing problems with younger children, except
for the three who still had problems with RAOM
and were treated with tympanostomy tubes. The
mild and varying conductive hearing loss of
these children accompanied the periods of
AOM. After 6 months of follow-up, no hearing
loss, facial paralysis or other residual symptoms
were found in any patient. No recurrent
mastoiditis was found. In previous reports, the
proportion of permanent hearing loss, facial
paresis and death has been 9-65% (Goldstein
et al. 1998, Albers 1999).
5.5 Acute complications of otitis
media in adults (IV)
During the 10-year study period 30 patients
[57%(17/30) males and 43%(13/30) females]
aged 16 to 75 years (mean 42.6 years) were
treated. The age-adjusted annual incidence was
0.3/ 100 000. There are no recent reports of the
incidence of the complications of OM in adults
in Finland. During 1956-1971 the incidence was
2.4/100 000 (Juselius and Kaltiokallio 1972).
In this study, there was no seasonal variation in
the incidence of the complications. Seventy-
three percent (22/30) of the complications were
intratemporal and 27%(8/30) were intracranial.
All the clinical records were available, and 67%
(20/30) of the patients responded to the
questionnaire.
Nine of the patients (30%) had a chronic disease
(IV, Table 1). Six patients (20%) had recurrent
AOM, and OME had been diagnosed earlier in
one (3%) patient. Two patients (7%) had a
history of mastoidectomy in the past because
of COM. The duration of ear symptoms before
admission to the hospital ranged from 1 to 28
days (mean 6.43 days), and 73% (22/30) of the
patients had been admitted to the hospital within
a week after the symptoms of complication had
appeared. The ear disease behind the acute
complication was AOM, COM and COM with
cholesteatoma in 70% (21/30), 17% (5/30) and
13% (4/30), respectively. Barry et al. (1999)
studied 79 adult patients with otogenic ITC. In
their material AOM, COM and COM with
cholesteatoma was diagnosed in 41%, 15% and
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22%, respectively. In this study, AOM was
diagnosed in 60% (18/30) of the patients before
the diagnosis of the complication, and these
patients were all on antibiotics before the
complication. Antibiotic treatment of the AOM
patients before the diagnosis of the
complication was statistically significantly
associated with a lower number of operative
treatments (7/18) when compared with no
antibiotic treatment before the complication
(11/12) (P<0.05), the finding agreeing with Van
Zuijlen et al. (2001).
The mastoiditis was classified as classical in
80% (24/30) of the cases and in 20% (6/30) it
was latent. Faye-Lund (1989) reported 27 cases
of acute or latent mastoiditis during 1985-1988
in Norway. Four (15%) of these were classified
latent mastoiditis. In this study, in the ITC group
mastoiditis was complicated by subperiosteal
abscess, labyrinthitis and facial paresis in 14%
(3/22), 18% (4/22) and 27% (6/22),
respectively. Fifty percent (4/8) of the ICC cases
were intracranial abscesses, 38% (3/8) were
meningitis, and 12% (1/8) were sigmoid sinus
thrombosis. The proportion of complicated
mastoiditis and ICC was higher than in previous
reports (Kangsanarak et al. 1995, Albers 1999,
Osma et al. 2000, Vassbotn et al. 2002). In this
study, the ICC cases were more often associated
with a prolonged duration of ear symptoms
(over 7 days) when compared with the ITC
cases, 5 of 8 and 5 of 22, respectively (P<0.05).
Latent mastoiditis was diagnosed in 63% (5/8)
of the ICC patients but only in 5% (1/22) of the
ITC patients (P<0.05). Holt and Gates (1983)
also showed the association of ICC of OM with
latent mastoiditis. They reported nine cases of
latent mastoiditis with ICC and extradural
abscess developed in two of these. In this study,
three of the four patients with cholesteatoma
had ICC. The duration of ear symptoms was
not statistically significantly associated with the
performed mastoidectomy or the duration of
hospitalization in the ITC group. All except one
of the patients with an ICC were operated on.
The only patient who was not operated on had
meningitis, and she died before the operative
treatment was performed.
Retroauricular tenderness was the most often
found local sign of complication in both the ITC
and ICC groups (IV, Table 2). Seventy-seven
percent of the patients (23/30) had only minor
general signs of infection, but 10% (3 with ICC)
had signs of septic infection with high fever and
changes in hemodynamics and the level of
consciousness. Adult patients seem to have less
local and general signs of infection than children
(Harley et al. 1997, Goldstein et al. 1998,
Tarantino et al. 2002). In this study, the ICC
patients more often had fever than did ITC
patients but the difference was not statistically
significant. Spontaneous perforations and
otorrhea occurred significantly more often with
an ITC than with an ICC (P<0.05). However,
there was no difference between an ITC and an
ICC in the frequency of other local signs of OM
and mastoiditis. The severity of general signs
and symptoms of infection at the time of
admittance was not statistically significantly
associated with the need for hospitalization for
more than 7 days. This is concordant with the
results of the studies in children (Goldstein et
al. 1998).
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The laboratory examination revealed variable
levels of CRP and white blood cell counts.
Neither a high CRP level (>100mg/ml) nor an
elevated white blood cell count (>15 000/mm³)
was statistically significantly associated with the
type of complication (ITC or ICC), the
performed mastoidectomy or hospitalization for
more than 7 days. A bacterial culture of the MEE
or ME was taken from 93% (24/30 from the
middle ear and 4/30 from the mastoid) of the
patients. S. pneumoniae (5/30) and S. pyogenes
(5/30) were the bacteria most often cultured,
followed by P. aeruginosa (4/30) (IV, Table 3).
In previous reports, S. pneumoniae and P.
aeruginosa have been the predominant bacteria
in ITCs of children (Goldstein et al.
1998,Tarantino et al. 2002), but there is a lack
of recent reports concerning adult OM patients
with an ITC. All the patients positive for P.
aeruginosa and Escherichia coli had COM,
prolonged AOM or cholesteatoma behind the
acute exacerbation of the ear disease. Of the
bacterial cultures from the MEE or ME of the
patients with intracranial abscesses, two grew
E. coli, one grew S. pneumoniae and one
showed M. catarrhalis. Of the three MEE
specimens from the patients with meningitis one
grew S. pneumoniae and two showed no growth.
These findings agree with the results of earlier
reports concerning otogenic ICCs (Kangsanarak
et al. 1995, Sennaroglu and Sozeri 2000). The
cultures and gram staining of the cerebrospinal
fluid of these patients were negative. Of the
abscess aspirates from the patients with brain
abscess, one grew E. coli, one grew
Fusobacterium necrophorum and Bacteroides
ureolyticus, but two aspirates were negative in
culture. Enterobacterieae or Bacteroides
species are often found in otogenic intracranial
abscesses (Mathisen and Johnson 1997,
Sennaroglu and Sozeri 2000). Barry et al.
(1999) have published a report on 79 adult
patients with otogenic intracranial infections,
and S. pneumoniae (48%) was the most
frequently found bacterium, followed by
anaerobes (7%) and H. influenzae (5%). In this
study, all the ICC patients were on antibiotic
medication before the cerebrospinal fluid or
abscess sample was obtained. There were no
differences in the bacterial susceptibility to
antibiotics according to the type of ear disease
behind the complication.
Plain radiography was the only radiographic
examination made for the patients with an ITC
or an ICC in 45% (10/22) and 13% (1/8) of the
cases, respectively. CT was performed in 55%
(12/22) of the ITC patients and in 87% (7/8) of
the ICC patients. MRI was done in 38% (3/8)
of the ICC patients, but none of the ITC
patients. At the end of the decade, CT was the
primary radiographic examination done for the
patients. All radiological examinations
suggested mastoiditis. CT identified
subperiosteal and intracranial abscesses in
100% (7/7) of the cases, but in three patients
the presence of cholesteatoma behind these
complications could not be verified. MRI was
used to further examine the localization and
spread of brain abscess after CT. These results
are in concordance with the present opinion of
the use of radiological imaging for these
complications (Yates et al. 2002, Vazquez et al.
2003).
The duration of hospitalization ranged from 2
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to 32 days (mean 8.2 days). Myringotomy
without tympanostomy tube insertion was done
in 40% (12/30) of the patients. Eight of them
were treated with a combination of antibiotic
and myringotomy without other operative
treatment. In the case of the remaining four
patients with myringotomies without
tympanostomy tube insertion, mastoidectomy
had also been carried out. A tympanostomy tube
was inserted in eight of the 30 patients (27%).
In two cases the tympanostomy tube insertion
was the only operative treatment. The remaining
six tympanostomy tube insertions were done
together with mastoidectomy. Mastoidectomy
was performed in 60% (18/30) of the patients,
and four of the operations were accompanied
by the evacuation of an intracranial abscess (IV,
Figure 1). This is markedly higher proportion
than 35% in previous report by Barry et al.
(1999) but lower than 88% in the study of
Vassbotn et al. (2002). In this study,
mastoidectomy was performed on all the
patients with a subperiosteal abscess or ICC.
All the patients with COM or cholesteatoma
underwent an operation. Facial decompression
was done in one patient (17%) with facial
paresis. Thirty-three percent (6/18) of the
operations were performed in 1990-1994 and
67% (12/18) took place in 1995-2000.
An audiometric evaluation was carried out at
least once in 83% (25/30) of the patients. Forty-
three percent (13/30) had hearing loss [PTA
(0.5-2kHz) more than 20 dB] during the 1-year
follow-up. The current acute complication of
OM induced permanent hearing loss, ranging
from 25 dB to total loss in the affected ear (mean
PTA 53 dB), in 30% (9/30) of the patients. The
hearing loss was conductive, sensorineural or
combined in 7% (2/30), 13% (4/30) and 10%
(3/30), respectively. The four patients with pure
sensorineural hearing loss all had labyrinthitis.
In 75% (3/4) of the patients with sensorineural
hearing loss, the affected ear became deaf
during the follow-up. One patient (3%) had
vertigo after 1 year of the onset of the OM
complication, but the vertigo was mild and did
not affect the patient´s daily living. In previous
studies, hearingloss and vestibular dysfunction
has been found in 6-17% of patients (Albers
1999, Barry et al. 1999).
Thirteen percent (4/30) of the patients suffered
from chronic serous OM after the complication.
One of them developed a chronic perforation
of the tympanic membrane, and a
tympanostomy tube was inserted in the
tympanic membrane of the other three. Seven
percent (2/30) of the patients needed continuous
follow-up after radical mastoid surgery. One of
these patients underwent a revision operation
because of residual cholesteatoma.
Five of the six patients (83%) with facial paresis
recovered completely. The patient who had total
facial paralysis at the onset of the complication
suffered from House grade III permanent facial
paralysis after 1 year of follow-up. Yetiser et
al. (2002) studied 24 patients with facial
paralysis due to COM and recovery was
achieved only in 60%. Ellefsen and Bonding
(1996) reported a material of 23 patients with
facial paralysis in AOM. They found full
recovery in 96% of patients.
Ten percent (3/30) of the patients have died. In
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one (3%) the death was a direct consequence
of the OM complication (meningitis). In two
(7%) the cause of death was not associated with
the ear disease. In the study of Albers (1999),
one of the 23 patients with ITC or ICC died. In
reports dealing with ICCs of OM the mortality
has been 4-23% (Kangsanarak et al. 1995, Yen
et al. 1995, Osma et al. 2000, Sennaroglu et al.
2000).
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6.1  Alloiococcus otitidis in AOM and
            OME  (I, II)
The results of this study show that A. otitidis
exists both in the MEE of AOM and OME. The
higher incidence of A. otitidis in the MEE of
older children is seen both in AOM and OME.
The reason for this finding is still unclear. A.
otitidis may be a harmless commensal in AOM
and OME (or the nasopharynx/ear canal), and
the higher incidence of A. otitidis in older
children may be the result of colonization of
this organism due to the interaction of children
in day care. In OME, the persistence of MEE
for 3 months or longer showed a marked
increase in the PCR samples positive for A.
otitidis. In addition, A. otitidis was detected
significantly more often in mucoid effusions
than in mucoserous ones. A. otitidis seems to
exist more prominently in chronic OME, and
this finding suggests the possibility that A.
otitidis could prolong the middle ear infection
and lead to OME. No other reports have been
published about the clinical association of A.
otitidis in OME. Future research is needed to
get more profound knowledge of the possible
pathogenetic role and mechanisms of A. otitidis
in OME.
The response to treatment with amoxicillin
clavulanate was similar for the A. otitidis-
positive and the A. otitidis-negative children in
AOM.  A. otitidis has been reported to be either
susceptible or intermediately resistant to
penicillin, ampicillin and 3rd generation
cephalosporins (Bosley et al. 1995). Therefore,
these results can only be used to evaluate the
clinical significance of A. otitidis in AOM
patients treated with amoxicillin clavulanate.  In
the future, the clinical significance of A. otitidis
in AOM needs to be studied prospectively in a
larger population
The multiplex PCR analysis of MEE samples
from AOM was found to be as sensitive as the
culture method, with the exception of the
analysis for H. influenzae. In previous studies
with MEE samples from OME (Hendolin et al.
1999, Hendolin et al. 2000) and in our OME
study, the number of the PCR-positive MEEs
has been significantly higher when compared
with the culture positive MEEs. This divergence
could be explained by the difference in the type
of effusion being analyzed. The extractability
of bacterial DNA from purulent effusion may
differ from that of the mucous or serous effusion
of OME. In addition, the extraction method
differed from that used in previous studies
(Hendolin et al. 2000). The DNA extraction was
initiated from cotton swabs that had been used
for the inoculation of the culture (i.e., the
extraction method did not represent a
homogeneous processing of the entire sample).
This extra step may have caused the premature
lysis of bacterial cells, particularly those of the
rigid gram-negative H. influenzae cells, and the
loss of amplifiable H. influenzae genomes.
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 In OME, A. otitidis was often associated with
S. pneumoniae and H. influenzae culture-
positive samples, but it was not found in the M.
catarrhalis culture-positive samples. A. otitidis
was detected by PCR more often in multiple
than in single positive specimens, but with M.
catarrhalis this relation was reversed. In
multiple positive MEE, M. catarrhalis was
significantly more often associated with gram-
positive cocci than with H. influenzae. These
findings indicate possible interactions between
the four bacteria studied. S. pneumoniae has
been shown to have an inhibitory effect on the
growth of H. influenzae and
M. catarrhalis in vitro (Pericone et al. 2000).
In an in vitro study, alpha-hemolytic
streptococcus has been shown to inhibit the
growth of S. pneumoniae, H. influenzae and M.
catarrhalis (Tano et al. 1999). On the other
hand, beta-lactamase-producing M. catarrhalis
may protect S. pneumoniae from beta-lactam
antibiotics (Budhani and Struthers 1998). It is
possible that microbial collaboration and
bacterial counteractions lead to changes in the
bacteriology of MEE over the course of OME.
Whether A. otitidis participates in these
interactions and hinders the growth of M.
catarrhalis is a question for further research.
6.2 Severe complications of OM (III,
IV,  V)
The availability of antibiotics decreased the
incidence of ITC and ICC in OM significantly
in Finland from the 1950s to the 1970s (Palva
and Pulkkinen 1959, Palva et al. 1985,
Tarkkanen and Kohonen 1970, Juselius and
Kaltiokallio 1972), and it has remained low ever
since both in adults and in children (0.3/100
000 and 1.1/100 000, respectively in the present
study). The incidence is low even when
compared with the reported incidences from the
other European countries (Petersen et al. 1998,
Van Zuijlen et al. 2001, Vassbotn et al. 2002).
Like in earlier reports (Ellefsen and Bonding
1996, Albers 1999, Osma et al. 2000)
concerning acute complications of AOM and
COM, also in this study, mastoiditis was the
most frequently found single ITC followed by
facial paralysis and labyrinthitis. All ICCs,
except one, were found in adult patients. The
overall number of ICCs was low, but the
proportion of intracranial abscesses was higher
than in previous reports (Kangsanarak et al.
1995, Albers 1999, Osma et al. 2000). The
development of ICC was due to the delay in the
diagnosis of the complication. This finding
reflects the difficulty in recognizing and
understanding the signs and symptoms of an
ongoing and progressing ear infection especially
in adults. Twenty-one of the adult patients had
AOM and 18 of them were on antibiotic
medication when the complication was
diagnosed. Furthermore, almost 20% of the
adult patients had a chronic ear disease that was
not diagnosed before the complication, and still
another 20% had a latent mastoiditis that had
been treated with one or more antibiotic courses
before the diagnosis of the complication. This
finding addresses the importance of the close
patient follow-up and the need for an early
otological evaluation of patients with prolonged
or progressing ear or neurological symptoms
suggesting a complicated ear disease.
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Retroauricular pain and fever were the clinical
signs of mastoiditis seen in most of the patients.
In adults, other signs of acute mastoiditis were
seen only rarely reflecting the differences in the
etiology and clinical picture between adult and
pediatric patients with complications of OM.
The reports dealing with the symptoms of ITC
and ICC of OM are mostly based on the material
from pediatric patients (Harley et al. 1997,
Goldstein et al. 1998, Vera-Cruz et al. 1999,
Tarantino et al. 2002) or from mixed population
of adult and pediatric patients (Kangsanarak et
al. 1995, Yen et al. 1995, Petersen et al. 1998,
Vassbotn et al. 2002). However, the clinical
picture, especially the local signs of ITC of OM
in adult patients, seems to be milder than in
children.
Only 10% (3/30) of the adult patients had signs
and symptoms of septic infection, and they all
had an ICC leading to operative treatment. Still,
in over half of the patients with ICC, the signs
of complication were mild and the symptoms
progressed over several days or even a few
weeks. In the material of 12 patients with ICC
of COM, Schwaber et al. (1989) found drainage
of the ear and fever in 75% and 25% of the
patients, respectively. More over, ear-related
signs and symptoms presented an early phase
of the developing infection, and neurological
alterations, except headache, were late-phase
symptoms that prompted the patient to seek for
treatment. In previous studies, cholesteatoma
has been found in over half of the otogenic ICCs
(Yen et al. 1995, Barry et al. 1999); this rate
being even higher than in the present series.
Therefore, the possibility of ICCs should be
remembered, especially when there is a latent
onset of symptoms of mastoiditis, signs of septic
infection, neurological symptoms or suspicion
of cholesteatoma.
Laboratory examinations, like CRP and white
blood cell count, can be used in the follow-up
of patients, but their diagnostic value is limited.
The diagnosis of complications of OM and the
related treatment decisions are based on the
clinical picture with the support from
radiological findings. During the first half of
the study period, plain mastoid radiographs
were used in most cases, and the operative
decisions were based primarily on the clinical
picture of the disease. Today CT is the
cornerstone of the radiological diagnosis of
acute ITC and ICC of OM. In this study,
temporal and cranial CT scans (when ICC was
suspected) identified both intratemporal and
intracranial abscesses, but cholesteatoma
behind the complication was often missed.
Therefore, radiological findings determine the
choice of surgical approach, but they contribute
less to the decision to operate or not and to the
prediction of potential hazards.
S. pneumoniae was the most frequently cultured
bacteria, as in most studies concerning acute
complications of OM (Petersen et al. 1998,
Tarantino et al. 2002, Vassbotn et al. 2002). P.
aeruginosa was found often, especially in
patients with RAOM or COM. M. catarrhalis
was found in one child with ITC and in one
adult with ICC. The clinical significance of M.
catarrhalis in AOM has increased markedly
over the past two decades, and it seems that it
is also capable of provoking serious
complications of OM. Despite the fact that the
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bacterial culture was negative in 27% (17/63)
of all patients and, in addition, two-thirds of
the patients who were on antibiotic treatment
before the complication had either accurate
antibiotic medication or no growth in the
culture, the infection still proceeded. This
finding points out the fact that the antibiotic
treatment of OM alone is sometimes not
effective enough, and patients with a prolonged
or rapidly progressing ear disease should be
treated in a unit with proper diagnostic and
otoneurosurgical facilities. Antibiotic resistance
in our material was low like in recent reports
from the United States and Israel (Bahadori et
al. 2000, Katz et al. 2003). However, the
bacteria cultured in the MEE or ME of our
patients were more resistant to the used
antibiotics than the bacteria found in an
uncomplicated AOM in Finland (Kilpi et al.
2001). Because of the variation in the
bacteriology of complicated OM and the threat
of growing antibiotic resistance, the bacterial
culture should always be done from MEE or
ME in a complicated OM.
Antibiotics form the basis for the treatment of
complications of OM, but the indications for
operative measures and their timing is a
constant subject of discussion in the literature.
Myringotomy with or without tympanostomy
tube placement is beneficial to ensure the
drainage of the middle ear and to harvest a
specimen for bacterial culture. In our study,
during the last half of the decade the number of
mastoidectomies performed in children
decreased, although the number of
complications slightly increased. This
conservative approach to the treatment of
complications of OM in pediatric patients is
supported by the reports of Goldstein et al.
(1998) and Taylor and Berkowitz (2004). On
the other hand, most adult patients with acute
complications of OM were treated surgically.
The time from the presentation of the ear
symptoms to the diagnosis of the complication
was not significantly associated with the
operative treatment. The consequences of
treatment delay however can be disastrous.
While the progression of infection can be rapid,
the patient with a complicated ear disease
should be followed closely, and the treatment
should be designed according to the patients
individual needs. According to the results of our
study and earlier studies (Goldstein et al. 1998,
Taylor and Berkowitz 2004), operative
treatment is suggested for patients with acute
complications of OM when there are signs of
abscess forming ITC or ICC or when COM or
cholesteatoma is behind the acute complication.
Mastoiditis without further complications
usually responds to more conservative
treatment.
In pediatric patients, mastoidectomy but no
facial decompression was done to all patients
with facial paralysis. However, it seems that
most of the pediatric patients with facial
paralysis will recover without operative
treatment (Elliot et al. 1996). All adult patients
with facial paralysis, except one, were treated
conservatively, with good recovery. The adult
patient with total facial paralysis was operated
on but the recovery was incomplete. Ellefsen
and Bonding (1996) have shown that recovery
is significantly associated with the severity of
facial paralysis in AOM, and this finding was
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apparent also in the present study. In adults,
facial paralysis associated with OM is often
accompanied with COM and cholesteatoma
(Osma et al. 2000, Yetiser et al. 2002). In our
material, only one patient with facial paralysis
had COM but none had cholesteatoma.
According to recent recommendations (Elliot
et al. 1996, Redaelli et al. 2003) otogenic facial
paralysis should be treated as conservatively as
possible, and mastoidectomy should be
performed only when it is necessary to treat OM
and its complications or when the facial
paralysis is total.
The response to treatment and the recovery of
the pediatric patients was good. Goldstein et
al. (1998) concluded in their report that ITC
often occurs after inadequately treated AOM.
In this study, there was no delay in the diagnosis
of ITC, which was probably the most important
factor explaining the good results. The child
with an extradural abscess and meningitis had
a 5-day history of AOM, and the signs of septic
infection developed in one day. He had an
unclassified developmental retardation and
problems with speech production, which may
have complicated the assessment of the signs
and symptoms of AOM and may have led to a
delay in the diagnosis and development of ICC.
Although untreated intratemporal and
intracranial AOM complications are potentially
life threatening, with accurate diagnostic
procedures and effective treatment started
without delay the prognosis is good.
The risk of a complicated middle ear infection
is low today, but the danger of complications
still remains. In this study, the proportion of
the adult patients with hearing loss was
significantly higher than in earlier reports (Yen
et al. 1995, Barry et al. 1999). Labyrinthitis
induced the most confound inner-ear damage,
and therefore it was the single most disabling
form of ITC. The hearing loss of the patients
with labyrinthitis was profound or total in all
cases. However, the vertigo associated with
labyrinthitis was well compensated in all the
patients. Antibiotic treatment has decreased the
mortality associated with the complications of
OM, but it is still high in countries with
a developing health care system (Samuel et al.
1986, Kangsanarak et al. 1995, Sennaroglu and
Sozeri 2000). The overall mortality associated
with the ITC and ICC of OM in this study
(3.3%) was at the same level as described earlier
(1.3-5%) (Leopold and Lagoe 1988, Yen et al.
1995, Barry et al. 1999). The mortality
associated with ICC (12.5%) was comparable
with the 10% reported by Gower and McGuirt
(1983). The death of one patient reminds of the
potential dangers of OM. Special awareness is
needed when a patient with OM complains
headache or develops neurological symptoms.
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This study was carried out to explore the
bacteriology and current clinical picture of OM
and its complications. Special interest was
focused on the incidence and clinical
association of A. otitidis in AOM and OME and
on the incidence and clinical picture of acute
complications of OM in children and adults.
Although not culturable, A. otitidis was detected
by PCR in a marked proportion of the MEE of
AOM. The results of this study suggest that, in
AOM treated with amoxicillin-clavulanate, A.
otitidis has no clinical significance, and it does
not increase the risk of OME developing after
AOM. However, the clinical significance of A.
otitidis in AOM needs to be studied
prospectively in a larger population.
PCR proved to be a sensitive and specific
method for detecting A. otitidis in MEE of
OME. A. otitidis was often found in mucoid
MEE (20%), and its presence in MEE correlated
significantly with the persistence of effusion in
the middle ear. This finding suggests that A.
otitidis could be one of the factors leading to
the prolongation of inflammation in the middle
ear and the development of OME.
Acute ITC and ICC of OM are rare today, but
they still have a hazardous potential even to
disable and lead to a lethal outcome. Among
children these complications are usually
intratemporal and present in conjunction with
AOM, but among adults ICCs and COM and
cholesteatoma behind the complication should
be suspected more easily, even if the patient
has not had earlier ear problems. In adults the
clinical picture of ITC and ICC of OM is often
slowly progressing and mild. However, the signs
of septic infection or neurological disturbances
strongly suggest ICC. The bacteriology and the
bacterial resistance to antibiotics in ITC and
ICC differ markedly from those of AOM.
Therefore, the bacterial etiology should always
be determined in the case of prolonged AOM.
Patients with a prolonged middle-ear infection
or with neurological symptoms secondary to
OM should be evaluated and treated in a unit
with otoneurosurgical facilities. Antibiotics are
the basis of the therapy. Operative treatment is
suggested in abscess forming ITC or ICC of
OM or when COM or cholesteatoma is found
to be behind these complications. With early
diagnosis and accurate treatment, the prognosis
of these complications is good.
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Välikorvatulehduksen komplikaatiot HYKS:n korva-, nenä- ja kurkkutautien klinikassa
1990-2000
Potilaskysely
Olkaa hyvä ja täyttäkää ensin henkilötieto-osa tutkimuksen myöhemmässä vaiheessa tapahtuvaa
tunnistusta varten. Tämän jälkeen seuraa kysymysosa, johon vastaatte laittamalla rastin kyllä, ei
tai en osaa sanoa ruutuun kunkin kysymyksen kohdalla. Lopuksi on vielä muutama tarkentava
sanallinen kysymys. Omia kommentteja (koskien esim. hoitoa,toipumista tai tätä tutkimusta) var-
ten on varattu tilaa lomakkeen loppuun.
Henkilötiedot:
Nimi: Syntymäaika:
Osoite
Kysymysosa
Välikorvatulehduksen riskitekijät
(sairastumisen aikoihin)
Kysymyksiin 1.-6. vastataan vain lapsipotilaiden osalta
1. Tupakointia kotona sisätiloissa?
2. Onko lasta imetetty? (kesto ____kk)
3. Onko sisaruksia? (lukumäärä ___)
4. Päivähoito kotona?
5. Päiväkodissa?
6. Perhepäivähoito?
7. Akuutteja välikorvatulehduksia yli 3/6kk?
8. Liimakorvatauti ennen komplikaation hoitoa?
9. Korvan tai kasvojen kehityspoikkeavuuksia?
10. Kromosomipoikkeavuuksia(esim. Down sdr)?
11. Huuli- tai suulakihalkio tiedossa?
12. Immuunipuutostauti tiedossa?
APPENDIX
ei                kyllä en osaasanoa
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Sukuhistoria
Välikorvatulehduksen komplikaatioilla tarkoitetaan seuraavassa välikorvatulehduksen aiheutta-
maa
- korvan seudun tai korvalokeroston märkäpesäkettä
- aivokalvon tulehdusta tai kallon sisäistä märkäpesäkettä
- tasapainoelimen tulehdusta
- kasvohermohalvausta
1. Vanhemmilla välikorvatulehduksia?
2. Vanhemmilla välikorvatulehduksen
            komplikaatioita?
3. Sisaruksilla välikorvatulehduksia?
4. Sisaruksilla välikorvatulehduksen
           komplikaatioita
Lapsen sairaushistoria
1.   Oliko lapsi/olitteko ennen sairaalaan
      joutumista ollut perusterve?
2.   Onko kroonisia sairauksia tiedossa?
3.   Oliko todettu liimakorvatautia ennen
      välikorvatulehduksen komplikaatiota?
4.   Onko liimakorvatautia nykyisin?
5.   Oliko kitarisa poistettu ennen komplikaatiota?
6.   Oliko tehty tärykalvoputkitusta ennen
     välikorvatulehduksen komplikaatiota?
Olkaa hyvä ja vastatkaa vielä alla oleviin kysymyksiin sikäli kuin pystytte
Oliko todettu välikorvatulehdus ennen komplikaatiota?
Sairaudet 2 viikkoa ennen komplikaatiota?
ei   kyllä
en osaa
sanoa
ei                kyllä
en osaa
sanoa
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Lääkitykset 2 viikkoa ennen komplikaatiota?
Tiedossa olevat krooniset sairaudet?
Sairaudet 3 kk ajalta ennen välikorvatulehduksen komplisoitumista?
Välikorvatulehdusten määrä kokonaisuudessaan ennen komplikaatiota?
Välikorvatulehdusten määrä komplikaatiota edeltäneen 6 kk aikana?
Montako kertaa kaikkiaan tehty kitarisan poisto?
Milloin viimeksi ennen välikorvatulehduksen komplikaatiota tehty kitarisan poisto? _____kk
Montako kertaa kaikkiaan laitettu tärykalvoputket?
Milloin viimeksi ennen välikorvatulehduksen komplikaatiota laitettu tärykalvoputket? _____kk
Onko välikorvatulehduksen komplikaation jälkeen ilmennyt ongelmia kuulossa?
Onko välikorvatulehduksen komplikaation jälkeen ollut haittaavaa huimausta?
83
Omat kommentit
Kiitos!
84
